Publications

Article Index

668. J. Deeg, I. Louban, D. Aydin, C. Selhuber-Unkel, H. Kessler, J. Spatz, Impact of Local versus Global Ligand Density on Cellular Adhesion, Nano Letters 2011, 11(4), 1469-1476.

667. O. Ovadia, J. Chatterjee, B. Laufer, F. Opperer, H. Kessler, C. Gilon, A. Hoffman, The effect of multiple N-methylation on intestinal permeability of cyclic hexapeptides, Mol. Pharmaceutics, 2011, 8, 479-487.

666. C. Mas-Moruno, F. Rechenmacher, H. Kessler; Cilengitide: the first anti-angiogenic small molecule drug candidate Design, synthesis and clinical evaluation, Anti-Cancer Agents In Medicinal Chemistry 2011, 10, 753-768.

665. M. Amela-Cortes, V. Roullier, C. Wolpert, S. Neubauer, H. Kessler, O. Bedel, S. Mignani, V. Marchi-Artzner, Stable functionalized PEGylated quantum dots micelles with a controlled stoichiometry, Chemcomm 2011, 47, 1246-1248.

664. J. Fiedler, J. Groll, E. Engelhardt, P. Gasteier, C. Dahmen, H. Kessler, M. Moeller, R. E. Brenner, NCO-sP(EO-stat-PO) surface coatings preserve biochemical properties of RGD peptides, Int. J. Mol. Medicine 2011, 27, 139-146.

663. F. Hagn, C. Thamm, T. Scheibel, H. Kessler; pH Dependent Dimerisation and Salt Dependent Stabilisation of the N-terminal Domain of Spider Dragline Silk - Implications for Fibre Formation, Angew. Chem. Int. Ed. 2011, 50, 310-313.

 


662. S. Kruss, T. Wolfram, R. Martin, S. Neubauer, H. Kessler, J. P. Spatz, Stimulation of Cell Adhesion at Nanostructured Teflon Interfaces, Advanced Materials, 2010, 22, 5499-5506.

661. A. O. Frank, E. Otto, C. Mas-Moruno, H. B. Schiller, L. Marinelli, S. Cosconati, A. Bochen, D. Vossmeyer, G. Zahn, R. Stragies, E. Novellino, H. Kessler; Conformational Control of Integrin Subtype Selectivity in isoDGR Peptide Motifs: A Biological Switch, Angew. Chem. Int. Ed. 2010, 49, 9278-9281.

660. I. Varnay, V. Truffault, S. Djuranovic, A. Ursinus, M. Coles, H. Kessler; Optimized measurement temperature gives access to the solution structure of a 49 kDa homohexameric β propeller, J. Amer. Chem. Soc. 2010, 132, 15692-15698.

659. D. Aydin, I. Louban, N. Perschmann, J. Blümmel, T. Lohmüller, E. A. Cavalcanti-Adam, T.L. Haas, H. Walczak, H. Kessler, R. Fiammengo, J. P. Spatz, Polymeric Substrates with Tunable Elasticity and Nanoscopically Controlled Biomolecule Presentation, Langmuir, 2010, 26 (19), 15472-15480.

658. S. Welker, B. Rudolph, E. Frenzel, F. Hagn, G. Liebisch, G. Schmitz, J. Scheuring, A. Kerth, A. Blume, S. Weinkauf, M. Haslbeck, H. Kessler, J. Buchner; Hsp12 is an Intrinsically Unstructured Stress Protein which folds upon Membrane Association and Modulates Membrane Function, Mol. Cell, 2010, 39 (4), 507-520.

657. L. Doedens, F. Opperer, M. Cai, J. G. Beck, M. Dedek, E. Palmer, V. J. Hruby, H. Kessler, Multiple N-methylation of MT-II backbone amide bonds leads to melanocortin receptor subtype hMC1R selectivity; pharmacological and conformational studies, J. Amer. Chem. Soc. 2010, 132 (23), 8115-8128.

656. A. G. F. de Beer, E. A. Cavalcanti-Adam, G. Majer, M. Lopez-Garcia, H. Kessler, J. P. Spatz, Force induced destabilization of adhesion complexes at defined integrin spacings on nanostructured surfaces, Physical Review E 81 2010, 051914 (1-7).

655. O. Ovadia, S. Greenberg, B. Laufer, C. Gilon, A. Hofmann, H. Kessler, Improvement of Drug Like Properties of Peptides: The Somatostatin paradigm, Expert Opin. Drug Discov. 2010, 5(7), 655-671.

654. B. Laufer, A. O. Frank, J. Chatterjee, T. Neubauer, C. Mas-Moruno, G. Kummerlöwe, H. Kessler, The Impact of Amino Acid Side Chain Mutations in Conformational Design of Peptides and Proteins, Chemistry Eur. J. 2010, 16, 5385-5390.

653. F. Hagn, L. Eisoldt, J. Hardy, C. Vendrely, M. Coles, T. Scheibel, H. Kessler, A highly conserved spider silk domain acts as a molecular switch that controls fibre assembly, Nature 2010, 465, 239-242.

652. C. Selhuber-Unkel, T. Erdmanm, M. Lopez-Garcia, H. Kessler, U.S. Schwarz, J.P. Spatz, Cell Adhesion Strength is controlled by Intermolecucar Spacing of Adhesion Receptors, Biophys. J. 2010, 98, 543-551 (featured article).

651. M. Retzlaff, F. Hagn, L. Mitschke, M. Hessling, F. Gugel, H. Kessler, K. Richter, J. Buchner, Asymmetric activation of the Hsp90 dimer by its co-chaperone Aha1, Mol. Cell 2010, 37, 344-354.

650. F. Hagn, C. Klein, O. Demmer, N. Marchenko, U. M. Moll, H. Kessler, BclxL Changes Conformation upon Binding to Wild-type but Not Mutant p53 DNA Binding Domain, J. Biol. Chem. 2010, 285, 3439-3450.

649. K.-H. Altmann, J. Buchner, H. Kessler, F. Diederich, B. Kräutler, S. Lippard, R. Liskamp, K. Müller, E. M. Nolan, B. Samori, G. Schneider, S.L. Schreiber, H. Schwalbe, C. Toniolo, C. A. A. van Boeckel, H. Waldmann, C.T. Walsh, The State of Art of Chemical Biology, Chembiochem 2009, 15, 16-29.

 

648. M. Retzlaf, M. Stahl, H. C. Eberl, S. Lagleder, J. Beck, H. Kessler, J. Buchner, Hsp90 is regulated by a switch point in the C-terminal domain, EMBO Reports 2009, 10, 1147-1153.

647.  O. Demmer, A.O. Frank, H. Kessler, Design of Cyclic Peptides - in Peptide and Protein Design for Biopharmaceutical Applications, Ed. K. J. Jensen, Wiley, 2009, 133 - 176.

646. M. Hoefling, H. Kessler, K.-E. Gottschalk, The Transmembrane Structure of Integrin aIIbb3 - Significance to Signal Transduction, Angew. Chem. Int. Ed. 2009, 48, 6590-6593.

645. T. Huber, F. Manzenrieder, C. A. Kuttruff, C. Dorner-Ciossek, H. Kessler, Prolonged stability by cyclization: Macrocyclic phosphino dipeptide isostere inhibitors of β-secretase (BACE1), Bioorg. Med. Chem. Lett. 2009, 19, 4427-4431.

644. M. J. Feige, S. Groscurth, M. Marcinowski, Y. Shimizu, H. Kessler, L. M. Hendershot, J. Buchner, An Unfolded CH1 Domain Controls the Assembly and Secretion of IgG Antibodies, Mol. Cell 2009, 34 (5), 569-579.

 

643. M. Schottelius, B. Laufer, H. Kessler, H.-J. Wester, Ligands for mapping avb3-integrin expression in vivo, Acc. Chem. Res. 2009, 42, 969-980.

642. O. Schnell, B. Krebs, J. Carlsen, I. Stangier, C. Goetz, R. H. Goldbrunner, H.-J. Wester, R. Haubner, G. Pöpperl, M. Holtmannspötter, H. Kessler, J.-C. Tonn, M. Schwaiger, A. J. Beer, Imaging of Integrin αvβ3 Expression in Patients with Malignant Glioma by [18F]Galacto-RGD Positron Emission Tomography, Neuro-Oncology, 2009, 11, 861-870.

 

641. M. Spichty, A. Taly, F. Hagn, H. Kessler, N. Winssinger, M. Karplus; The Hsp90 binding mode of a radicicol-like E-oxime from docking, binding free energy estimations, and NMR shifts; Biophys. Chem. 2009, 143, 111-123.

640. M. J. Pandya, H. Bendz, F. Manzenrieder, E. Noessner, H. Kessler, J. Buchner, R. D. Issels, Interaction of human heat shock protein 70 with tumour-associated peptides, Biological Chemistry 2009, 390, 305-312.

639. J.H. Huang, S.V. Graeter, F. Corbellini, S. Rinck, E. Bock, R. Kernkerner, H. Kessler, J.D. Ding, J.P. Spatz, Impact of Order and Disorder in RGD Nanopatterns on Cell Adhesion, Nanoletters 2009, 9, 1111-1116.

638. D. Heckmann, B. Laufer, L. Marinelli , V. Limongelli, E. Novellino, G. Zahn, R. Stragies, H. Kessler;  Breaking the dogma of carboxylate group as metal coordinating agent in integrin ligands: targeting of the MIDAS by hydroxamic acids to tune potency and selectivity; Angew. Chem. Int. Ed. 2009, ASAP.

637. M. Arnold, M. Schwieder, J. Blummel, E.A. Cavalcanti-Adam, M. Lopéz-García, H. Kessler, B. Geiger, J. Spatz, Soft Matter 2009, 5 (1), 72-77.

636. B. Laufer, J. Chatterjee, A. O. Frank, H. Kessler, Can N-Methylated Amino Acids Serve as Substitute for Prolines in Conformational Design of Cyclic Pentapeptides? , J. Pept. Sci. 2009, 15, 141-146.

635. C. Selhuber-Unkel, M. López-García, H. Kessler, J.P. Spatz, Cooperativity in Adhesion Cluster Formation during Initial Cell Adhesion, Biophys. J. 2008, 95, 5424-5431.

634. J. Klages, A. Kotzsch, M. Coles, J. Nickel, T. Müller, H. Kessler, The solution structure of BMPR-IA reveals a local disorder-to-order transition upon BMP-2 binding, Biochemistry 2008, 47, 11930-11939.

633. G. Kummerlöwe, S. Knör, A. Frank, T. Paululat, H. Kessler, B. Luy, Deuterated Polymer Gels for Measuring Anisotropic NMR Parameters with Strongly Reduced Artefacts, Chem. Commun. 2008, 5722-5724.

632. M. Pellecchia, I. Bertini, D. Cowburn, C. Dalvit, E. Giralt, W. Jahnke, T. L. James, S. W. Homans, H. Kessler, C. Luchinat, B. Meyer, H. Oschkinat, J. Peng, H. Schwalbe, G. Siegal. Perspectives on NMR in Drug Discovery: A Technique Comes of Age, Nat. Rev. Drug Disc. 2008, 7, 738-745.

631. A. Enthart, J. C. Freudenberger, J. Furrer, H. Kessler, B. Luy, The CLIP/CLAP-HSQC: Pure Absorptive Spectra for the Measurement of One-Bond Couplings, J. Magn. Res. 2008, 192 (2), 314-322.

630. M.J. Feige, S. Groscurth, M. Marcinowski, Z.T. Yew, V. Truffault, E. Paci, H. Kessler, J. Buchner, The structure of a folding intermediate explains differences in immunoglobulin amyloidogenicity, PNAS 2008, 105 (36), 13373-13378.

629. M. Arnold, V.C. Hirschfeld-Warneken, T. Lohmüller, P. Heil,  J. Blummel, E.A. Cavalcanti-Adam, M. Lopez-Garcia, P. Walther, H. Kessler, B. Geiger, J.P. Spatz, Induction of cell polarization and migration by a gradient of nanoscale variations in adhesive ligand spacing, Nanoletters 2008, 8 (7), 2063-2069.

628. J. Chatterjee, C. Gilon, A. Hoffman, H. Kessler, N-Methylation of Peptides: A New Perspective in Medicinal Chemistry, Acc. Chem. Res. 2008, 41, 1331-1342.

627. D. Kaufmann, A. Fiedler, A. Junger, J. Auernheimer, H. Kessler, R. Weberskirch, Chemical conjugation of linear and cyclic RGD moieties to a recombinant elastin-mimetic polypeptide - A versatile approach towards bioactive protein hydrogels, Macromolecular Bioscience 2008, 8(6), 577-588.

626. O. Demmer, I. Dijkgraaf, M. Schottelius, H.-J. Wester, H.Kessler, Introduction of Functional Groups into Peptides via N-Alkylation, Org. Lett. 2008, 10 (10), 2015-2018.

625. S. Kalinina; H. Gliemann; M. Lopez-Garcia; J. Auernheimer; T.Schimmel; M. Bruns; A. Schambony; H. Kessler; D. Wedlich, Isothiocyanate-functionalized RGD-peptides as useful alternative in tailoring cell-adhesive surface patterns, Biomaterials 2008, 29, 3004-3013.

624. V. C. Hirschfeld-Warneken, M. Arnold, A. Cavalcanti-Adam, M. López-García, H. Kessler, J. P. Spatz, Cell Adhesion and Polarisation on Molecularly Defined Spacing Gradient Surfaces of Cyclic RGDfK Peptide Patches, Eur.J.Cell Biol. 2008, 87, 743-750.

623. D. Heckmann, A. Meyer, B. Laufer, G. Zahn, R. Stragies, H. Kessler, Rational Design of Highly Active and Selective Ligands for α5β1 Integrin Receptor, ChemBioChem. 2008, 9, 1397-1407.

622. A.O. Frank, H. Kessler, The sweetest candy for the virus, Nature (News and Views) 2008, 452 (April 17), 822-823.

621.  F. Manzenrieder, A. O. Frank, H. Kessler, Phosphorus NMR as Versatile Tool for Compound Library Screening, Angew.Chem Int. Ed. 2008, 47 (14), 2608-2611.

620. T. Higuchi, F.M. Bengel, S. Seidl, P. Watzlowik, H. Kessler, R. Hegenloh, S. Reder, S. G. Nekolla, H.-J. Wester, ; M. Schwaiger,  Assessment of αvβ3 Integrin Expression after Myocardial Infarction by Positron Emission Tomography, Cardiovasc. Res. 2008, 78, 395-403.

619. E. Biron, J. Chatterjee, O. Ovadia, D. Langenegger, J. Brueggen, D. Hoyer, H. Schmid,R. Jelinek, C. Gilon, A. Hoffman, H. Kessler, Improved Oral Bioavailability of Peptides via N-Methylation: Somatostatin Analogs, Angew.Chem Int. Ed. 2008, 47 (14), 2595-2599.

618. S. Knör, A. Khrenov, B. Laufer, A. Benhida, S. C. Grailly, R. Schwaab, J. Oldenburg, J.-M. R. Saint-Remy, E. L. Saenko, C. A. E. Hauser, H. Kessler, Efficient factor VIII affinity purification using a small synthetic ligand, J. Thromb. Haemostasis 2008, 6 (3), 470-477.

617. J. Chatterjee, D. Mierke, H. Kessler, Conformational Preference and Potential Templates of N-Methylated Cyclic Pentaalanine Peptides, Chemistry Eur. J. 2008, 14 (5), 1508-1517.

616. B. Luy, A. Frank, H. Kessler, “Conformational Analysis of Drugs by NMR Spectroscopy” in Molecular Drug Properties: Measurement and Prediction. Eds. R. Mannhold, H. Kubinyi, G. Folkers, Methods and Principles in Medicinal Chemistry, Vol. 37, Wiley, 2007, p.207-254.

615. J. Chatterjee, O. Ovadia, G. Zahn, L. Marinelli, A. Hoffman, C. Gilon, H. Kessler, Multiple N-Methylation by a Designed Approach Enhances Receptor Selectivity, J. Med. Chem. 2007, 50, 5878-5881.

614. S. Knör, S. Sato, T. Huber, A. Morgenstern, F. Bruchertseifer, M. Schmitt, H. Kessler, R.  Senekowitsch-Schmidtke, V. Magdolen, C. Seidl;  Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in α-emitter therapy of disseminated ovarian cancer, Eur. J. of Nuclear Med. Mol. Imag. 2008, 35, 53-64.

613. O. Lieleg, M. López-García, C. Semmrich, J. Auernheimer, H. Kessler and A. R. Bausch, Specific integrin labelling in living cells using functionalized nanocrystals, Small 2007, 3 (9), 1560-1565.

612. J. Klages, H. Kessler, S. J. Glaser, B. Luy; J-ONLY-TOCSY: Efficient Suppression of RDC-Induced Transfer in Homonuclear TOCSY Experiments Using JESTER-1-Derived Multiple Pulse Sequences, J. Magn. Res. 2007, 189, 217-227.

611. J. Furrer, M. John, H. Kessler; B. Luy; J-Spectroscopy in the Presence of Residual Dipolar Couplings: Determination of One-Bond Coupling Constants and Scalable Resolution, J. Biomol. NMR 2007, 37, 231-243.

610. D. Heckmann, H. Kessler, Design and Chemical Synthesis of Integrin Ligands, Methods in Enzymology 2007, 426, 463-503.

609. J. Blümmel, N. Perschmann, D. Aydin, J. Drinjakovic, T. Surrey, M. López-García , H. Kessler, J. P. Spatz, Protein Repellent Properties of Covalently Attached PEG Coatings on Nanostructured SiO2 Based Interfaces, Biomaterials 2007, 28, 4739-4747.

608. S. Knör, A. V. Khrenov, B. Laufer, E. L. Saenko, C. A. E. Hauser, H. Kessler, Development of a peptidomimetic ligand for efficient isolation and purification of factor VIII via affinity chromatography, J. Med. Chem. 2007, 50, 4329-4339.

607. S.V. Graeter, J. Huang, N. Perschmann, M. Lopez-Garcia, H. Kessler, J. Ding, J. P. Spatz, Mimicking Cellular Environments by Nanostructured Soft Interfaces, Nanoletters 2007, 7 (5), 1413-1418.

606. M. López-García, H, Kessler; Stimulation of Bone growth on implants by integrin ligands. Chapt. 8 in Handbook of Biomineralization, Eds. M. Epple, E. Baeuerlein, Wiley, Weinheim, 2007, pp.109-126.

605. S. Takahashi, M. Leiss, M. Moser, T. Ohashi, T. Kitao, D. Heckmann, A. Pfeifer, H. Kessler, J. Takagi, H. P. Erickson, R. Fässler, The RGD motif in fibronectin is essential for development but dispensable for fibril assembly, J. Cell Biol. 2007, 178 (1), 167-178.

604. S. Knör , A. Modlinger, T. Poethko, M. Schottelius, H.-J. Wester, H. Kessler, Synthesis of Novel 1,4,7,10-Tetraazacyclodecane-1,4,7,10-Tetraacetic Acid (DOTA) Derivatives for Chemoselective Attachment to Unprotected Polyfunctionalized Compounds, Chemistry Eur. J. 2007, 13(21), 6082-6090.

603. F. Manzenrieder, A. Frank, T. Huber, C. Dorner-Ciossek, H. Kessler; Synthesis and biological evaluation of phosphino dipeptide  isostere inhibitor of human β-secretase (BACE1) Bioorg. & Med. Chem. 2007, 15, 4136-4143.

602. E. Ada Cavalcanti-Adam, T. Volberg, A. Micoulet, H. Kessler, B. Geiger, J. P. Spatz; Cell Spreading and Focal Adhesion Dynamics are Regulated by Spacing of Integrin Ligands; Biophysical Journal 2007, 92, 2964-2974.

601. B. Luy, H. Kessler; Partial Alignment for Structure Determination of Organic Molecules; in “Handbook of Modern NMR-Methods”; Eds.: G. Webb, D. Craik;  Kluwer Academic Publishers, 2007, p.1261-1267.

600. D. Heckmann, A. Meyer, L. Marinelli, G. Zahn, R. Stragies, H. Kessler, Probing Integrin Selectivity: Rational Design of Highly Active and Selective Ligands for the a5b1 and avb3 Integrin Receptor. Angew. Chem. 2007, 119 (19), 3641-3644; Angew. Chem. Int. Ed. 2007, 46, 3571-3574.

599.
J. Furrer, M. John, H. Kessler; B. Luy; J-Spectroscopy in the Presence of Residual Dipolar Couplings: Determination of One-Bond Coupling Constants and Scalable Resolution, J. Biomol. NMR, 2006, 37 (3), 231-243.

598.
H. Kessler, J. Klages; Lead Search and Optimization: NMR in Drug Discovery“ (Vol. 3, p. 901-920) in „Comprehensive Medicinal Chemistry II“ (Eds.: D.J. Triggle and J.B. Taylor). Elsevier, Oxford 2006, ISBN 0080445136.

597.
M. J. Feige, F. Hagn, J. Eßer, H. Kessler, J. Buchner; Influence of the internal disulfide bridge on the folding pathway of the CL antibody domain; J.Mol. Biol. 2006, 365, 1232-1244.

596. 
J. Chatterjee, D. Mierke, H. Kessler, N-methylated Cyclic Penta-Alanine Peptides as Template Structures, J.Am.Chem.Soc. 2006, 128, 15164-15172.

595.
A. J. Beer, R. Haubner, M. Sarbia, M. Goebel, S. Luderschmidt, A. Ligia Grosu, O. Schnell, M. Niemeyer, H. Kessler, H.-J. Wester, W. A. Weber, M. Schwaiger; Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man; Clinical Cancer Res. 2006, 12 (13), 3942-3949.

594. 
M. Heller, M. Sukopp, N. Tsomaia, M. John, D. F. Mierke, B. Reif, H. Kessler, The Conformation of Cyclo(-d-Pro-Ala4-): a Model for dl4 Cyclic Pentapeptides; J.Am.Chem.Soc. 2006, 128, 13806-13814.

593.
M. G. Friedel, J. C. Pieck, J. Klages, C. Dauth, H. Kessler, T. Carell; Synthesis and Stereochemical Assignment of DNA Spore Photoproduct Analogues; Chem. Eur.J. 2006, 12, 6081-6094.

592.
L. Römer, C. Klein, A. Dehner, H. Kessler, J. Buchner, p53 – a Natural Cancer Killer: Structural Insights and Therapeutic Concepts; Angew.Chem. Int. Ed. 2006, 45 (39), 6440-6460.

591.
A. Meyer, J. Auernheimer, A. Modlinger, H. Kessler; Targeting RGD Recognizing Integrins: Drug Development, Biomaterial Research, Tumor Imaging and Targeting; Curr. Pharmaceutical Design 2006, 12 (22), 2723 - 2747.

590.
S. Knoer, D. Heckmann, H. Kessler; Efficient enantioselective synthesis of condensed and aromatic ring-substituted tyrosine derivative; J.Org.Chem. 2006, 71 (15), 5625-5630.

589.
T. Weide, A. Modlinger, H. Kessler; Spatial Screening for the Identification of the Bioactive Conformation of Integrin Ligands; Topics in Curr. Chemistry 2007, 272, 1-50.

588.
M. V. Deshmukh, M. John, M. Coles, J. Peters, W. Baumeister, H. Kessler; Inter-domain orientation and motions in VAT-N explored by RDCs and 15N backbone relaxation; Magn. Res. Chem. 2006, 44, S89-S100.

587.
D. Lössner, H. Kessler, G. Thumshirn, C. Dahmen, M..Tanaka, W. Knoll, E.-K. Sinner, U. Reuning; Monitoring of the Binding of Small Mono- and Oligomeric Integrin Ligands to Membrane-Embedded Integrins by Surface Plasmon-Enhanced Fluorescence Spectroscopy; Analytical Chemistry 2006, 78 (13), 4524-4533.

586.
U. Magdolen, J- Auernheimer, C. Dahmen, J. Schauwecker, H. Gollwitzer, J. Tübel, R. Gradinger, H. Kessler, M. Schmitt, P. Diehl; Growth promoting in vitro effect of synthetic cyclic RGD-peptides on human osteoblast-like cells attached to cancellous bond; Internat. J. Molecular Medicine 2006, 17, 1017-1021.

585.
E. Biron, J. Chatterjee, H. Kessler; Solid-Phase Synthesis of Azole-Based Peptides and Peptidomimetics; Org. Lett. 2006, 8 (11), 2417-2420.

584.  
M. John, M. Wendeler, M. Heller, K. Sandhoff, H. Kessler; Characterization of Human Saposins by NMR Spectroscopy; Biochemistry 2006, 45, 5206-5216.

583.
J. Klages, M. Coles, H. Kessler; NMR-Based Screening: A Powerful Tool in Fragment-Based Drug Discovery; in “Exploiting Chemical Diversity for Drug Discovery” (Eds.: P. A. Bartlett, M. Entzeroth); RSC Publishing, Cambridge, 2006, Chapter 12; p. 263-290 and Mol.BioSyst. 2006, 2, 318-332.

582.
M. Haupt, M. Bramkamp, M. Coles, H. Kessler, K. Altendorf; The Prokaryotic Kdp-ATPase: Recent Insights in Structure and Function of KdpB; J. Mol.Microbiol. Biotechnol. 2006, 10, 120-131.

581.
M. Haupt, M. Bramkamp, M. Heller, M. Coles, G. Deckers-Hebestreit, B. Herkenhoff-Hesselmann, K. Altendorf, H. Kessler; The Holo-form of the Nucleotide Binding Domain of the KdpFABC Complex from  E. coli Reveals a New Binding Mode; J. Biol. Chem. 2006, 281(14), 9641-9649.

580.
E.A. Cavalcanti-Adam, A. Micoulet, J. Blümmel, J. Auernheimer, H. Kessler, J.P.Spatz; Lateral spacing of integrin ligands influences cell spreading and focal adhesion assembly; Eur. J. Cell Biol. 2006, 85 (3-4), 219-224.

579.
N. Walter, C. Selhuber, H. Kessler, J.P. Spatz; Cellular Unbinding Forces of Initial Adhesion processes on Nanopatterned Surfaces Probed with Magnetic Tweezers: Nano Letters 2006, 6 (3), 398-402.

578.
J. Auernheimer, R. Haubner, M. Schottelius, H.-J. Wester, H. Kessler; Radio-analytical determination of the coating efficiency of cyclic RGD-peptides; Helv Chim Acta 2006, 89, 833-840.

577.
K. Richter, S. Moser, F. Hagn, R. Friedrich, O. Hainzl, M. Heller, S. Schlee, H. Kessler, J. Reinstein, J. Buchner; Intrinsic Inhibition of the Hsp90 ATPase activity; J. Biol. Chem.2006, 281, 11301-11311.

576.
E. Biron, J. Chatterjee, H. Kessler; Optimized Selective N-Methylation of Peptides on Solid Support; J. Peptide Sci. 2006, 12, 213-219.

575.
Y. Tomita, N. Marchenko, S. Erster, A. Nemajerova, A. Dehner, C. Klein, H. Pan, H. Kessler, P. Pancoska, U. M. Moll; WT p53 but not tumor-derived mutants bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization; J. Biol. Chem. 2006, online

574.
S. Cesana, J. Auernheimer, R. Jordan, H. Kessler, O. Nuyken; First Poly(2- oxazoline)s with Pendant Amino Groups; Macromol. Chem. Phys. 2006, 207, 183-192

573.
J. Auernheimer, H. Kessler; Benzylprotected aromatic phosphonic acids for anchoring peptides on titanium; Bioorg. Med. Chem. Lett. 2006, 16, 271-273

572.
T. Weide, L. Arve, H. Prinz, H. Waldmann, H. Kessler; 3-Substituted Indolizine-1-carbonitrile Derivatives as Phosphatase Inhibitors; Bioorg. Med.Chem. Lett. 2006, 16, 59-63

571.
H.-J. Wester, H. Kessler; Molecular Targeting with Peptides or Peptide-Polymer-Conjugates: just a question of size?; J. Nucl. Med. 2005, 46, 1940 -1945.

570.
J. Auernheimer, C. Dahmen, U. Hersel, A. Bausch, H. Kessler; Photo Switched Cell Adhesion on Surfaces with RGD Peptides; J. Amer. Chem. Soc. 2005, 127, 16107-16110.

569.
J. Auernheimer, C. Dahmen, M. Kantlehner, A. Enderle, D. Zukowski, S. L. Goodman, H. Kessler; Titanium Implant Materials with Improved Biocompatibility via Coating with Cyclic RGD-Peptides via Phosphonates; ChemBioChem 2005, 6, 2034-2040.

568.
J. Klages, C. Neubauer, M. Coles, H. Kessler, B. Luy; Structure Refinement of Cyclosporin A  in Chloroform by Using RDCs Measured in a Stretched PDMS-Gel; ChemBioChem 2005, 6, 1672-1678.

567.
A. Dehner, H. Kessler; Diffusion NMR Spectroscopy: Folding and Aggregation of Domains in p53; ChemBioChem 2005, 6, 1550-1565.

566.
H. Schwalbe, H. U. Stilz, H. Kessler; NMR Spectroscopy of Biomacromolecules in Drug Discovery and Beyond; ChemBioChem 2005, 6, 1475-1478.

565.
A. Dehner, C. Klein, S. Hansen, L. Müller, J. Buchner, M. Schwaiger, H. Kessler; Cooperative Binding of p53 to DNA: Regulation by Protein-Protein Interactions through a Double Salt Bridge; Angew. Chem. 2005, 117, 5381-5386; Angew. Chem. Int. Ed. 2005, 44, 5247-5251.

564.
T. Arndt, U. Arndt, U. Reuning, H. Kessler; Integrins in Angiogenesis: Implications for Tumor Therapy. – In: Cancer Therapy. Molecular Targets in Tumor-Host Interactions. Ed.: G. F. Weber; Horizon Bioscience, Norfolk, U.K. 2005, 93-141.

563.
L. Marinelli, A. Meyer, D. Heckmann, A. Lavecchia, E. Novellino, H. Kessler; Ligand Binding Analysis for Human α5β1 Integrin: Strategies for Designing New α5β1 Integrin Antagonists; J. Med. Chem. 2005, 48, 4204-4207.

562.
E. Biron, H. Kessler; Convenient Synthesis of N-Methylamino Acids Compatible with Fmoc Solid-Phase Peptide Synthesis; J. Org. Chem. 2005, 70, 5183-5189.

561.
B. Luy, K. Kobzar, S. Knör, J. Furrer, D. Heckmann, H. Kessler; Orientational Properties of Stretched Polystyrene Gels in Organic Solvents and the Suppression of Their Residual 1H NMR Signals; J. Am. Chem. Soc. 2005, 127, 6459-6465.

560.
K. Kobzar, H. Kessler, B. Luy; Stretched Gelatin Gels as Chiral Alignment Media for the Discrimination of Enantiomers by NMR Spectroscopy; Angew. Chem. 2005, 117, 3205-3207; Angew. Chem. Int. Ed. 2005, 44, 3145-3147.

559.
R. Haubner, W. A. Weber, A. J. Beer, E. Vabuliene, D. Reim, M. Sarbia, K.-F. Becker, M. Goebel, R. Hein, H.-J. Wester, H. Kessler, M. Schwaiger; Noninvasive Visualization of the Activated αvβ3 Integrin in Cancer Patients by Positron Emission Tomography and [18F]Galacto-RGD; PLoS Medicine 2005, 2, 244-252.

558.
M. Sukopp, R. Schwab, L. Marinelli, E. Biron, M. Heller, E. Várkondi, A. Pap, E. Novellino, G. Kéri, H. Kessler; Structure-Activity Relationship Studies Optimizing the Antiproliferative Activity of Novel Cyclic Somatostatin Analogues Containing a Restrained Cyclic β-Amino Acid; J. Med. Chem. 2005, 48, 2916-2926.

557.
M. V. Deshmukh, G. Voll, A. Kühlewein, H. Mäcke, J. Schmitt, H. Kessler, G. Gemmecker; NMR Studies Reveal Structural Differences between the Gallium and Yttrium Complexes of DOTA-D-Phe1-Tyr3-octreotide; J. Med. Chem. 2005, 48, 1506-1514.

556.
E. Lieb, M. Hacker, J. Tessmar, L. A. Kunz-Schughart, J. Fiedler, C. Dahmen, U. Hersel, H. Kessler, M. B. Schulz, A. Göpferich; Mediating specific cell adhesion to low-adhesive diblock copolymers by instant modification with cyclic RGD peptides; Biomaterials 2005, 26, 2333-2341.

555.
V. Beck, H. Herold, A. Benge, B. Luber, P. Hutzler, H. Tschesche, H. Kessler, M. Schmitt, H.-G. Geppert, U. Reuning; ADAM15 decreases integrin αvβ3/vitronectin-mediated ovarian cancer cell adhesion and motility in an RGD-dependent fashion; Int. J. Biochem. & Cell Biol. 2005, 37, 590-603.

554.
J. C. Freudenberger, S. Knör, K. Kobzar, D. Heckmann, T. Paululat, H. Kessler, B. Luy; Stretched Poly(vinyl acetate) Gels as NMR Alignment Media for the Measurement of Residual Dipolar Couplings in Polar Organic Solvents; Angew. Chem. 2005, 117, 427-430; Angew. Chem. Int. Ed. 2005, 44, 423-426.

553.
T. Poethko, M. Schottelius, G. Thumshirn, M. Herz, R. Haubner, G. Henriksen, H. Kessler, M. Schwaiger, H.-J. Wester; Chemoselective pre-conjugate radiohalogenation of unprotected mono- and multimeric peptides via oxime formation; Radiochimica Acta 2004, 92, 317-327.

552.
M. Schottelius, T. Poethko, M. Herz, J.-C. Reubi, H. Kessler, M. Schwaiger, H.-J. Wester; First 18F-Labeled Tracer Suitable for Routine Clinical Imaging of sst Receptor-Expressing Tumors Using Positron Emission Tomography; Clinical Cancer Res. 2004, 10, 3593-3606.

551.
C. Dahmen, J. Auernheimer, A. Meyer, A. Enderle, S. L. Goodman, H. Kessler; Improving Implant Materials by Coating with Nonpeptidic, Highly Specific Integrin Ligands; Angew. Chem. 2004, 116, 6818-6821; Angew. Chem. Int. Ed. 2004, 43, 6649-6652.

550. 
J. C. Freudenberger, P. Spiteller, R. Bauer, H. Kessler, B. Luy; Stretched Poly(dimethylsiloxane) Gels as NMR Alignment Media for Apolar and Weakly Polar Organic Solvents: In Ideal Tool for Measuring RDCs at Low Molecular Concentrations; J. Am. Chem. Soc. 2004, 126, 14690-14691.

549.
M. Haupt, M. Bramkamp, M. Coles, K. Altendorf, H. Kessler; Inter-domain Motions of the N-domain of the KdpFABC Complex, a P-type ATPase, are not Driven by ATP-induced Conformational Changes; J. Mol. Biol. 2004, 342, 1547-1558.

548.
A. Kühlewein, G. Voll, B. Hernandez Alvarez, H. Kessler, G. Fischer, J.-U. Rahfeld, G. Gemmecker; Solution structure of Escherichia coli Par10: The prototypic member of the Parvulin family of peptidyl-prolyl cis/trans isomerases; Protein Sci. 2004, 13, 2378-2387.

547.
L. Marinelli, K.-E. Gottschalk, A. Meyer, E. Novellino , H. Kessler; Human Integrin αvβ5: Homology Modeling and Ligand Binding; J. Med. Chem. 2004, 47, 4166-4177.

546.
M. Haupt, M. Coles, V. Truffault, M. Bramkamp, K. Altendorf, H. Kessler; Letter to the Editor: 1H. 13C and 15N resonance assignment of the nucleotide binding domain of KdpB from Escherichia coli; J. Biomol. NMR 2004, 29, 437-438.

545.
S. Pallu, R. Bareille, M. Dard, H. Kessler, A. Jonczyk, M. Vernizeau, J. Amédée-Vilamitjana; A cyclo peptide activates signaling events and promotes growth and the production of the bone matrix; Peptides 2003, 24, 1349-1357.

544.
K.-E. Gottschalk, H. Kessler; A Computational Model of Transmembrane Integrin Clustering; Structure 2004, 12, 1109-1116.

543.
K.-E. Gottschalk, M. Soskine, S. Schuldiner , H. Kessler; A Structural Model of EmrE, a Multi-Drug Transporter from Escherichia coli; Biophys. J. 2004, 86, 3335-3348.

542.
T. Poethko, M. Schottelius, G. Thumshirn, U. Hersel, M. Herz, G. Henriksen, H. Kessler, M. Schwaiger, H.-J. Wester; Two-Step Methodology for High-Yield Routine Radiohalogenation of Peptides: 18F-Labeled RGD and Octreotide Analogs; J. Nucl. Med. 2004, 45, 892-902.

541.
C. Riemer, T. Bayer, H. Schmitt, H. Kessler; 3-Azido-aspartic acid derivatives – orthogonally protected precursors for the stereoselective incorporation of 2,3-diaminosuccinic acid into peptide structures; J. Peptide Res. 2004, 63, 196-199.

540.
M. Arnold, E. A. Cavalcanti-Adam, R. Glass, J. Blümmel, W. Eck, M. Kantlehner, H. Kessler, J. P. Spatz; Activation of Integrin Function by Nanopatterned Adhesive Interfaces; ChemPhysChem 2004, 5, 383-388.

539.
F. Kramer, M. V. Deshmukh, H. Kessler, S. J. Glaser; Residual Dipolar Coupling Constants: An Elementary Derivation of Key Equations; Concepts Magn. Reson. 2004, 21A, 10-21.

538. 
M. John, M. Heller, M. Coles, G. Bosch, W. Baumeister , H. Kessler; Letter to the Editor: 1H, 15N and 13C resonance assignments of α-ADT and β-ADT; J. Biomol. NMR 2004, 29, 209-210.

537.
R. Haubner, F. Bruchertseifer, M. Bock, H. Kessler, M. Schwaiger, H.-J. Wester; Synthesis and biological evaluation of a 99mTc-labelled cyclic RGD peptide for imaging the αvβ3 expression; Nuklearmedizin 2004, 43, 26-32.

536. 
M. Wendeler, J. Hoernschemeyer, M. John, N. Werth, M. Schoeniger, T. Lemm, R. Hartmann, H. Kessler, K. Sandhoff; Expression of the GM2-activator protein in the methylotrophic yeast Pichia pastoris, purification, isotopic labeling, and biophysical characterization; Protein Expr. Purif. 2004, 34, 147-157.

535.
D. D. Boyd, H. Wang, H. Avila, N. U. Parikh, H. Kessler, V. Magdolen, G. E. Gallick; Combination of an Src Kinase Inhibitor with a Novel Pharmacological Antagonist of the Urokinase Receptor Diminishes in Vitro Colon Cancer Invasiveness; Clinical Cancer Res. 2004, 10, 1545-1555.

534.
B. Luy, K. Kobzar, H. Kessler; An Easy and Scalable Method for the Partial Alignment of Organic Molecules for Measuring Residual Dipolar Couplings; Angew. Chem. 2004, 116, 1112-1115; Angew. Chem. Int. Ed. 2004, 43, 1092-1094.

533.
M. Heller, M. John, M. Coles, G. Bosch, W. Baumeister, H. Kessler; NMR Studies on the Substrate-binding Domains of the Thermosome: Structural Plasticity in the Protrusion Region; J. Mol. Biol. 2004, 336, 717-729

532.
R. Haubner, B. Kuhnast, C. Mang, W. A. Weber, H. Kessler, H.-J. Wester, M. Schwaiger; [18F]Galacto-RGD: Synthesis, Radiolabeling, Metabolic Stability, and Radiation Dose Estimates; Bioconjugate Chem. 2004, 15 61-69

531. 
K.-E. Gottschalk, H. Kessler; Evidence for hetero-association of transmembrane helices of integrins; FEBS Lett. 2004, 557, 253-258

530.
E. Locardi, J. Boer, A. Modlinger, A. Schuster, B. Holzmann, H. Kessler; Synthesis and Structure-Activity Relationship of Mannose-Based Peptidomimetics Selectively Blocking Integrin α4β7 Binding to Mucosal Addressin Cell Adhesion Molecule-1; J. Med. Chem. 2003, 46, 5752-5762.

529.
E. Mann, H. Kessler; New Oxazole-Based Peptidomimetics: Useful Building Blocks for the Synthesis of Orthogonally Protected Macrocyclic Scaffolds; Org. Lett. 2003, 5, 4567-4570.

528.
L. Marinelli, A. Lavecchia, K.-E. Gottschalk, E. Novellino, H. Kessler; Docking Studies on avb3 Integrin Ligands: Pharmacophore Refinement and Implications for Drug Design; J. Med. Chem. 2003, 46, 4393-4404.

527.
R. Dawson, L. Müller, A. Dehner, C. Klein, H. Kessler, J. Buchner; The N-terminal Domain of p53 is Natively Unfolded; J. Mol. Biol. 2003, 332, 1131-1141.

526.
R. M. van Well, L. Marinelli, C. Altona, K. Erkelens, G. Siegal, M. van Raaij, A. L. Llamas-Saiz, H. Kessler, E. Novellino, A. Lavecchia, J. M. van Boom, M. Overhand; Conformational Analysis of Furanoid e-Sugar Amino Acid Containing Cyclic Peptides by NMR Spectroscopy, Molecular Dynamics Simulation, and X-ray Crystallography: Evidence for a Novel Turn Structure; J. Am. Chem. Soc. 2003, 125, 10822-10829.

525.
A. Dehner, J. Furrer, K. Richter, I. Schuster, J. Buchner, H. Kessler; NMR Chemical Shift Perturbation Study of the N-Terminal Domain of Hsp90 upon Binding of ADP, AMP-PNP, Geldanamycin, and Radicicol; ChemBioChem 2003, 4, 870-877.

524.
M. Coles, M. Heller, H. Kessler ; NMR-based screening technologies; Drug Discovery Today 2003, 8, 803-810.

523.
U. Hersel, C. Dahmen, H. Kessler; RGD modified polymers: biomaterials for stimulated cell adhesion and beyond; Biomaterials 2003, 24, 4385-4415.

522.
B. Dittrich, T. Koritsnzky, M. Grosche, W. Scherer, R. Flaig, A. Wagner, H. G. Krane, H. Kessler, C. Riemer, A. M. M. Scheurs, P. Luger; Reproducability and transferability of topological properties; experimental charge density of the hexapeptide cyclo-(D,L-Pro)2-(L-Ala)4 monohydrate; Acta Cryst. 2002, B58, 721-727.

521.
U. Reuning, S. Sperl, C. Kopitz, H. Kessler, A. Krüger, M. Schmitt, V. Magdolen; Urokinase-type Plasminogen Activator (uPA) and ist Receptor (uPAR): Development of Antagonists of uPA/uPAR Interaction and their Effects In Vitro and In Vivo; Current Pharmaceutical Design 2003, 9, 1529-1543.

520.
J. Furrer, A. Enthart, A. Kühlewein, A. Dehner, C. Klein, S. Hansen, M. Schwaiger, H. Kessler, G. Gemmecker; Letter to the Editor: Backbone 1H, 13C and 15N resonance assignments for the 25.8 kDa DNA binding domain of the human p63 protein; J. Biomol. NMR 2003, 26, 377-378.

519.
S. Hapke, H. Kessler, B. Luber, A. Benge, P. Hutzler, H. Höfler, M. Schmitt, U. Reuning; Ovarian Cancer Cell Proliferation and Motility Is Induced by Engagement of Integrin avb3/Vitronectin Interaction; Biol. Chem. 2003, 384, 1073-1083.

518.
R. M. van Well, L. Marinelli, K. Erkelens, G. A. van der Marel, A. Lavecchia, H. S. Overkleeft, J. H. van Boom, H. Kessler, M. Overhand; Synthesis and Structural Analysis of Cyclic Oligomers Consisting of Furanoid and Pyranoid e-Sugar Amino Acids; Eur. J. Org. Chem. 2003, 2303-2313.

517.
G. Thumshirn, U. Hersel, S. L. Goodman, H. Kessler; Multimeric Cyclic RGD Peptides as Potential Tools for Tumor Targeting: Solid-Phase Peptide Synthesis and Chemoselective Oxime Ligation; Chem. Eur. J. 2003, 9, 2717-2725.

516.
D. Weber, C. Berger, P. Eickelmann, J. Antel, H. Kessler; Design of Selective Peptidomimetic Agonists for the Human Orphan Receptor BRS-3; J. Med. Chem. 2003, 46, 1918-1930.

515.
E. Guthaus, N. Schmiedeberg, M. Bürgle, V. Magdolen, H. Kessler, M. Schmitt; The Urokinase Receptor (uPAR, CD87) as a Target for Tumor Therapy: uPA-Silica Particles (SP-uPA) as a New Tool for Assessing Synthetic Peptides to Interfere with uPA/uPA-Receptor Interaction; Recent Results Cancer Res. 2003, 162, 3-14.

514.
R. Mühlberger, R. Robelek, W. Eisenreich, C. Ettenhuber, E. K. Sinner, H. Kessler, A. Bacher, G. Richter; RNA DNA Discrimination by the Antitermination Protein NusB; J. Mol. Biol. 2003, 327, 973-983.

513.
C. Dahmen, A. Janotta, D. Dimova-Malinovska, S. Marx, B. Jeschke, B. Nies, H. Kessler, M. Stutzmann; Surface functionalization of amorphous silicon and silicon suboxides for biological applications; Thin Solid Films 2003, 427, 201-207.

512.
H. Kessler, M. Heller, G. Gemmecker, T. Diercks, E. Planker, M. Coles; NMR in Medicinal Chemistry. - In: Small Molecule - Protein Interactions (Ernst Schering Research Foundation, Workshop 42) Eds.: H. Waldmann, M. Koppitz; Springer Verlag Berlin, Heidelberg 2003, 59-85.

511.
V. Marchi-Artzner, B. Lorz, C. Gosse, L. Jullien, R. Merkel, H. Kessler, E. Sackmann; Adhesion of Arg-Gly-Asp (RGD) Peptide Vesicles onto an Integrin Surface: Visualization of the Segregation of RGD Ligands into the Adhesion Plaques by Fluorescence; Langmuir 2003, 19, 835-841.

510.
E. Gräfin von Roedern, M. A. Born, M. Stöckle, H. Kessler; Synthesis of Peptides with Sugar Amino Acids. - In: Houben-Weyl: Methods of Organic Chemistry. Vol. E 22c: Synthesis of Peptides and Peptidomimetics; Eds.: M. Goodman, A. Felix, L. Moroder, C. Toniolo; Thieme Verlag, Stuttgart, New York 2003, 807-821.

509.
J. Gante, H. Kessler, C. Gibson; Synthesis of Azapeptides. - In: Houben-Weyl: Methods of Organic Chemistry. Vol. E 22c: Synthesis of Peptides and Peptidomimetics; Eds.: M. Goodman, A. Felix, L. Moroder, C. Toniolo; Thieme Verlag, Stuttgart, New York 2003, 311-323.

508.
C. Gilon, M. A. Dechantsreiter, F. Burkhart, A. Friedler, H. Kessler; Synthesis of N-Alkylated Peptides. In: Houben-Weyl: Methods of Organic Chemistry. Vol. E 22c: Synthesis of Peptides and Peptidomimetics; Eds.: M. Goodman, A. Felix, L. Moroder, C. Toniolo; Thieme Verlag, Stuttgart, New York 2003, 215-271.

507.
E. Locardi, H. Kessler; High Resolution NMR Spectroscopy. - In: Houben-Weyl: Methods of Organic Chemistry. Vol. E 22b: Synthesis of Peptides and Peptidomimetics; Eds.: M. Goodman, A. Felix, L. Moroder, C. Toniolo; Thieme Verlag, Stuttgart, New York 2003, 670-679.

506.
C. Gilon, C. Mang, E. Lohof, A. Friedler, H. Kessler; Synthesis of Cyclic Peptides. - In: Houben-Weyl: Methods of Organic Chemistry. Vol. E 22b: Synthesis of Peptides and Peptidomimetics; Eds.: M. Goodman, A. Felix, L. Moroder, C. Toniolo; Thieme Verlag, Stuttgart, New York 2003, 461-542.

505.
M. Sukopp, L. Marinelli, M.. Heller, T. Brandl, R. W. Hoffmann, H.. Kessler; Evaluation of structural features of a designed beta-turn mimic by incorporation into a cyclic RGD peptide. - In: Peptides 2002 (Proc. 27th European Peptide Symp., Aug. 31 - Sept. 6, 2002, Sorrento, Italy) Eds.: E. Benedetti, C. Pedone; Edizioni Ziino, Napoli, Italy, 2002, 898-899.

504.
C. Dahmen, U. Hersel, M. Kantlehner, J. Auernheimer, D. Finsinger, J. Meyer, P. Schaffner, A. Jonczyk, B. Diefenbach, B. Nies, H. Kessler; Biofunctionalization of different surface types via αvβ3 integrin selelctive RGD peptides. - In: Peptides 2002 (Proc. 27th European Peptide Symp., Aug. 31 - Sept. 6, 2002, Sorrento, Italy) Eds.: E. Benedetti, C. Pedone; Edizioni Ziino, Napoli, Italy, 2002, 456-457.

503.
G. Thumshirn, G. A. G. Sulyok, D. Weber, S. L.. Goodman, M. Wiesner, H. Kessler; Synthesis and biological evaluation of highly active nonpeptidic αvβ3 integrin antagonists. - In: Peptides 2002 (Proc. 27th European Peptide Symp., Aug. 31 - Sept. 6, 2002, Sorrento, Italy) Eds.: E. Benedetti, C. Pedone; Edizioni Ziino, Napoli, Italy, 2002, 298-299.

502.
T. Arndt, D. Gottschling, J. Boer, A. Schuster, B. Holzmann, H. Kessler; Peptide derived non-peptidic αvβ7-integrin antagonists. - In: Peptides 2002 (Proc. 27th European Peptide Symp., Aug. 31 - Sept. 6, 2002, Sorrento, Italy) Eds.: E. Benedetti, C. Pedone; Edizioni Ziino, Napoli, Italy, 2002, 22-23.

501. M. Sukopp, L. Marinelli, M. Heller, T. Brandl, S. L. Goodman, R. W. Hoffmann, H. Kessler; Designed Beta-Turn Mimic Based on the Allylic-Strain Concept: Evaluation of Structural and Biological Features by Incorporation into a Cyclic RGD Peptide (Cyclo(-L-arginylglycyl-L-(-aspartyl-)); Helv. Chim. Acta 2002, 85, 4442-4452.

500.
Z. Szabo, M. Tönnis, H. Kessler, M. Feldbrügge; Structure-function analysis of lipopeptide pheromones from the plant pathogen Ustilago maydis; Mol. Genet. Genomics 2002, 268, 362-370.

499.
N. Schmiedeberg, M. Schmitt, C. Rolz, V. Truffault, M. Sukopp, M. Burgle, O. G. Wilhelm, W. Schmalix, V. Magdolen, H. Kessler; Synthesis, Solution Structure, and Biological Evaluation of Urokinase Type Plasminogen Activator (uPA)-Derived Receptor Binding Domain Mimetics; J. Med. Chem. 2002, 45, 4984-4994.

498.
M. Bürgle, S. Sperl, J. Stürzebecher, A. Krüger, W. Schmalix, H. Kessler, L. Moroder, V. Magdolen, O. G. Wilhelm, M. Schmitt; The urokinase-type plasminogen activator (uPA) system: a new target for tumor therapy. In: Proteinase and Peptidase Inhibition: Recent potential targets for drug Development; Eds.: H. J. Smith, C. Simons; Taylor & Francis; London, New York 2002, 231-248.

497.
K.-E. Gottschalk, H. Kessler; The Structures of Integrins and Integrin-Ligand Complexes: Implications for Drug Design and Signal Transduction; Angew. Chem. 2002, 114, 3919-3927; Angew. Chem. Int. Ed. 2002, 41, 3767-3774.

496.
S. Sato, C. Kopitz, W. A. Schmalix, B. Muehlenweg, H. Kessler, M. Schmitt, A. Krüger, V. Magdolen; High-affinity urokinase-derived cyclic peptides inhibiting urokinase/urokinase receptor-interaction: effects on tumor growth and spread; FEBS Lett. 2002, 528, 212-216.

494.
D. Gottschling, J. Boer, A. Schuster, B. Holzmann, H. Kessler; Combina-torial and Rational Strategies To Develop Nonpeptidic a4b7-Integrin Antagonists from Cyclic Peptides; Angew. Chem. 2002, 114, 3133-3137; Angew. Chem. Int. Ed. 2002, 41, 3007-3011.

495.
S. A. W. Gruner, V. Truffault, G. Voll, E. Locardi, M. Stöckle, H. Kessler; Design, Synthesis, and NMR Structure of Linear and Cyclic Oligomers Containing Novel Furanoid Sugar Amino Acids; Chem. Eur. J. 2002, 8, 4365-4376.

493.
D. Weber, C. Berger, T. Heinrich, P. Eickelmann, J. Antel, H. Kessler; Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3; J. Peptide Sci. 2002, 8, 461-475.

492.
M. Stöckle, G. Voll, R. Günther, E. Lohof, E. Locardi, S. Gruner, H. Kessler; Synthesis and NMR Studies of Cyclopeptides Containing a Sugar Amino Acid; Org. Lett. 2002, 4, 2501-2504.

491.
B. Jeschke, J. Meyer, A. Jonczyk, H. Kessler, P. Adamietz, N. M. Meenen, M. Kantlehner, C. Goepfert, B. Nies; RGD-peptides for tissue engineering of articular cartilage; Biomaterials 2002, 23, 3455-3463.

490.
K. Prechtel, A. R. Bausch, V. Marchi-Artzner, M. Kantlehner, H. Kessler, R. Merkel; Dynamic Force Spectroscopy to Probe Adhesion Strength of Living Cells; Phys. Rev. Lett. 2002, 89, 028101-1 – 028101-4.

489.
K. E. Gottschalk, P. D. Adams, A. T. Brunger, H. Kessler; Transmembrane signal transduction of the aIIbb3 integrin; Protein Science 2002, 11, 1800-1812.

488.
D. Gottschling, J. Boer, L. Marinelli, G. Voll, M. Haupt, A. Schuster, B. Holzmann, H. Kessler; Synthesis and NMR Structure of Peptidomimetic a4b7-Integrin Antagonists; ChemBioChem 2002, 3, 575-578.

487.
K. E. Gottschalk, R. Günther, H. Kessler; A Three-State Mechanism of Integrin Activation and Signal Transduction for Integrin αvβ3; ChemBioChem 2002, 3, 470-473.

486.
H. Lüttgen, R. Robelek, R. Mühlberger, T. Diercks, S. C. Schuster, P. Köhler, H. Kessler, A. Bacher, G. Richter; Transcriptional Regulation by Antitermination. Interaction of RNA with NusB Protein and NusB/NusE Protein Complex of Escherichia coli; J. Mol. Biol. 2002, 316, 875-885.

485.
E. Guthaus, M. Bürgle, N. Schmiedeberg, S. Hocke, A. Eickler, M. D. Kramer, C. G. J. F. Sweep, V. Magdolen, H. Kessler, M. Schmitt; uPA-Silica-Particles (SP-uPA): A Novel Analytical System to Investigate uPA-uPAR Interaction and to Test Synthetic uPAR Antagonists as Potential Cancer Therapeutics; Biol. Chem. 2002, 383, 207-216.

484.
S. L. Goodman, G. Hölzemann, G. A. G. Sulyok, H. Kessler; Nanomolar Small Molecule Inhibitors for avb6, avb5, and avb3 Integrins; J. Med. Chem. 2002, 45, 1045-1051.

483.
S. A. W. Gruner, E. Locardi, E. Lohof, H. Kessler; Carbohydrate-Based Mimetics in Drug Design: Sugar Amino Acids and Carbohydrate Scaffolds; Chem. Rev. 2002, 102, 491-514.

482.
  N. Schmiedeberg, H. Kessler; Reversible Backbone Protection Enables Combinatorial Solid-Phase Ring-Closing Metathesis Reaction (RCM) in Peptides; Org. Lett. 2002, 4, 59-62.

481.
S.A.W. Gruner, H. Kessler, G. Kéri, A. Venetianer; Active Somatostatin Analogues Containig Sugar Amino Acids – in: Peptides: The Wave of the Future (Proc. 2nd Intern. and 17th American Peptide Symp., June 9-14, 2001, San Diego, California, USA) Eds.: M. Lebl, R. A. Houghten; American Peptide Society, San Diego, 2001, 664-665.

480.
H. Kessler, J. Boer, D. Gottschling, N. Schmiedeberg, C. Rölz, V. Truffault, B. Holzmann, A. Schuster, M. Bürgle, O. Wilhelm, V. Magdolen, M. Schmitt; Peptidic Inhibitors for Protein-Protein Interactions at Cell Surfaces – in: Peptides: The Wave of the Future (Proc. 2nd Intern. and 17th American Peptide Symp., June 9-14, 2001, San Diego, California, USA) Eds.: M. Lebl, R. A. Houghten; American Peptide Society, San Diego, 2001, 647-649.

479.
J. Boer, E. Locardi, A. Schuster, B. Holzmann, H. Kessler; ß-D-Mannose Based Peptidomimetics in the Design of α4β1 and avb7 Antagonists – in: Peptides: The Wave of the Future (Proc. 2nd Intern. and 17th American Peptide Symp., June 9-14, 2001, SanDiego, California, USA) Eds.: M. Lebl, R. A. Houghten; American Peptide Society, San Diego, 2001, 612-613.

478.
C. Klein, E. Planker, T. Diercks, H. Kessler, K.-P. Künkele, K. Lang, S. Hansen, M. Schwaiger; NMR Spectroscopy Reveals the Solution Dimerization Interface of p53 Core Domains Bound to Their Consensus DNA; J. Biol. Chem. 2001, 276, 49020-49027.

477.
S. A. W. Gruner, G. Kéri, R. Schwab, A. Venetianer, H. Kessler; Sugar Amino Acid Containing Somatostatin Analogues that Induce Apoptosis in Both Drug-Sensitive and Multidrug-Resistant Tumor Cells; Org. Lett. 2001, 3, 3723-3725.

476.
D. Gottschling, J. Boer, A. Schuster, B. Holzmann, H. Kessler; Cellular Solid-Phase Binding Assay and Mass Spectrometry for Screening of a4b7 Integrin Antagonists; Bioorg. Med. Chem. Lett. 2001, 11, 2997-3000.

475.
M. Heller, H. Kessler; NMR spectroscopy in drug design (Hungarian-German-Italian-Polish Joint Meeting on Medicinal Chemistry; September 2-6, 2001, Budapest, Hungary) Pure Appl. Chem. 2001, 73, 1429-1436.

474.
R. Haubner, H. J. Wester, W. A. Weber, W. Linke, C. Bodenstein, H. Kessler, M. Schwaiger; Improved Pharmacokinetics of [18F]RGD-Peptides by Serine-Conjugation (14. Intern. Symp. on Radiopharmaceutical Chemistry, Interlaken, Schweiz, 10.-15.06.2001) J. Labelled Cpd. Radiopharm. 2001, 44 (Suppl. 1) S157-S159.

473.
R. Haubner, W. A. Weber, H. J. Wester, S. I. Ziegler, E. Vabuliene, E. K. Chorianopoulos, H. Kessler, M. Schwaiger; Non-Invasive Determination of the αvβ3 Integrin Expresssion Using [18F]Galacto-RGD and PET (14. Intern. Symp. on Radiopharmaceutical Chemistry, Interlaken, Schweiz, 10.-15.06.2001) J. Labelled Cpd. Radiopharm. 2001, 44 (Suppl. 1) S96-S98.

472.
J. Boer, D. Gottschling, A. Schuster, B. Holzmann, H. Kessler; Design, Synthesis, and Biological Evaluation of α4β1 Integrin Antagonists Based on β-D-Mannose as Rigid Scaffold; Angew. Chem. 2001, 113, 3988-3991; Angew. Chem. Int. Ed. 2001, 40, 3870-3873.

471.
E. Locardi, M. Stöckle, S. Gruner, H. Kessler; Cyclic Homooligomers from Sugar Amino Acids: Synthesis, Conformational Analysis, and Significance; J. Am. Chem. Soc. 2001, 123, 8189-8196.

470.
V. Magdolen, M. Bürgle, N. Arroyo de Prada, N. Schmiedeberg, C. Riemer, F. Schroeck, J. Kellermann, K. Degitz, O. G. Wilhelm, M. Schmitt, H. Kessler; Cyclo19,31[D-Cys19]-uPA19-31 Is a Potent Competitive Antagonist of the Interaction of Urokinase-Type Plasminogen Activator with Its Receptor (CD87); Biol. Chem. 2001, 382, 1197-1205.

469.
J. Boer, D. Gottschling, A. Schuster, M. Semmrich, B. Holzmann, H. Kessler; Design and Synthesis of Potent and Selective α4β7 Integrin Antagonists; J. Med. Chem. 2001, 44, 2586-2592.

468.
S. Hapke, H. Kessler, N. Arroyo de Prada, A. Benge, M. Schmitt, E. Lengyel, U. Reuning; Integrin αvβ3/Vitronectin Interaction Affects Expression of the Urokinase System in Human Ovarian Cancer Cells; J. Biol. Chem. 2001, 276, 26340-26348.

467.
A. Dehner, E. Planker, G. Gemmecker, Q. B. Broxterman, W. Bisson, F. Formaggio, M. Crisma, C. Toniolo, H. Kessler; Solution Structure, Dimerization, and Dynamics of a Lipophilic α/310-Helical, Cα–Methylated Peptide. Implications for Folding Membrane Proteins; J. Am. Chem. Soc. 2001, 123, 6678-6686.

466.
V. Truffault, M. Coles, T. Diercks, K. Abelmann, S. Eberhardt, H. Lüttgen, A. Bacher, H. Kessler; The Solution Structure of the N-terminal Domain of Riboflavin Synthase; J. Mol. Biol. 2001, 309, 949-960.

465.
G.A.G. Sulyok, C. Gibson, S.L. Goodman, G. Hölzemann, M. Wiesner, H. Kessler; Solid-Phase Synthesis of a Nonpeptidic RGD Mimetic Library: New Selective αvβ3 Integrin Antagonists; J. Med. Chem. 2001, 44, 1938-1950.

464.
T. Diercks, M. Coles, H. Kessler; Applications of NMR in drug discovery; Curr. Opin. Chem. Biol. 2001, 5, 285-291.

463.
T. Bayer, C. Riemer, H. Kessler; A New Strategy for the Synthesis of Cyclopeptides Containing Diaminoglutaric Acid; J. Peptide Sci. 2001, 7, 250-261.

462.
R. Haubner, H.-J. Wester, W. A. Weber, C. Mang, S. I. Ziegler, S. L. Goodman, R. Senekowitsch-Schmidtke, H. Kessler, M. Schwaiger; Noninvasive Imaging of αvβ3 Integrin Expression Using 18F-labeled RGD-containing Glycopeptide and Positron Emission Tomography; Cancer Res. 2001, 61, 1781-1785.

461.
S. Gruner, H. Kessler; Linear and Cyclic Oligomers of Two New Furanoid Sugar Amino Acids. – In: Peptides 2000 (Proc. 26th European Peptide Symposium, Sept. 10-15, 2000, Montpellier, France) Eds.: J. Martinez, J.-A. Fehrentz; Editions EDK, Paris, France 2001, 313-314.

460.
R. Haubner, H.-J. Wester, F. Burkhart, R. Senekowitsch-Schmidtke, W. Weber, S. L. Goodman, H. Kessler, M. Schwaiger; Glycosylated RGD-Containing Peptides: Tracer for Tumor Targeting and Angiogenesis Imaging with Improved Biokinetics; J. Nucl. Med. 2001, 42, 326-336.

459.
V. Marchi-Artzner, B. Lorz, U. Hellerer, M. Kantlehner, H. Kessler, E. Sackmann; Selective Adhesion of Endothelial Cells to Artificial Membranes with a Synthetic RGD-Lipopeptide; Chem. Eur. J. 2001, 7, 1095-1101.

458.
C. Gibson, G.A.G. Sulyok, D. Hahn, S.L. Goodman, G. Hölzemann, H. Kessler; Bibliotheken niedermolekularer αvβ3-Integrin-antagonisten: On-Bead-Screening und massenspektrometrische Identifizierung ohne Codierung; Angew. Chem. 2001, 113, 169-173; Angew. Chem. Int. Ed. 2001, 40, 165-169.

457.
N. Schmiedeberg, M. Bürgle, O. Wilhelm, F. Lottspeich, H. Graeff, M. Schmitt, V. Magdolen, H. Kessler; Design and biological activity of new high-affinity ligands for the urokinase-type plasminogen activator receptor (CD87). - In: Peptides for the New Millennium(Proc. 16th American Peptide Symposium, June 26-July 1, 1999, Minneapolis, Minnesota, USA) Eds.: G. B. Fields, J. P. Tam, G. Barany; Kluwer Academic Publishers, Dordrecht, The Netherlands 2000, 543-545.

456.
H. Kessler, M. Kantlehner, C. Gibson, R. Haubner, D. Finsinger, M. Dechantsreiter, E. Planker, J. Wermuth, J. S. Schmitt, J. Meyer, P. Schaffner, G. Hölzemann, M. Wiesner, S. L. Goodman, D. Hahn, A. Jonczyk, H. J. Wester, M. Schwaiger; Recent progress in the field of αv-integrin antagonists. - In: Peptides for the New Millennium (Proc. 16th American Peptide Symposium, June 26-July 1, 1999, Minneapolis, Minnesota, USA) Eds.: G. B. Fields, J. P. Tam, G. Barany; Kluwer Academic Publishers, Dordrecht, The Netherlands 2000, 235-237.

455.
H. Kessler; Hoffnung auf neues Krebsmedikament; Spektrum der Wissenschaft (Nov.) 2000, 48-53.

454.
C. Gibson, G. Sulyok, J. S. Schmitt, M. A. Dechantsreiter, R. Haubner, G. Hölzemann, S. L. Goodman, H. Kessler; From Proteins to Drugs: The RGD Story. - In: The 8th Akabori Conference (Proc. 8th Akabori Conference, Japanese-German Symposium on Peptide Science, April 26-29, 2000, Nagoya, Japan) Ed.: T. Shioiri; Akabori Conference Association, Nagoya, Japan, 2000, 1-5.

453.
B. Hu, D. Finsinger, K. Peter, Z. Guttenberg, M. Bärmann, H. Kessler, A. Escherich, L. Moroder, J. Böhm, W. Baumeister, Sen-fang Sui, E. Sackmann; Intervesicle Cross-Linking with Integrin aIIbb3 and Cyclic-RGD-Lipopeptide. A Model of Cell-Adhesion Processes; Biochemistry 2000, 39, 12284-12294.

452.
C. Glaubitz, A. Gröger, K. Gottschalk, P. Spooner, A. Watts, S. Schuldiner, H. Kessler; 31P-CP-MAS NMR studies on TPP+ bound to the ion-coupled multidrug transport protein EmrE; FEBS Lett. 2000, 480, 127-131.

451.
M. Kantlehner, P. Schaffner, D. Finsinger, J. Meyer, A. Jonczyk, B. Diefenbach, B. Nies, G. Hölzemann, S. L. Goodman, H. Kessler; Surface Coating with Cyclic RGD Peptides Stimulates Osteoblast Adhesion and Proliferation as well as Bone Formation; ChemBioChem 2000, 1, 107-114.

450.
E. Lohof, E. Planker, C. Mang, F. Burkhart, M. A. Dechantsreiter, R. Haubner, H.-J. Wester, M. Schwaiger, G. Hölzemann, S. L. Goodman, H. Kessler; Kohlenhydratderivate im Wirkstoffdesign am Beispiel von cyclischen αv-selektiven RGD-Peptiden; Angew. Chem. 2000, 112, 2868-2871; Angew. Chem. Int. Ed. 2000, 39, 2761-2764.

449.
M. Schmitt, O. G. Wilhelm, U. Reuning, A. Krüger, N. Harbeck, E. Lengyel, H. Graeff, B. Gänsbacher, H. Kessler, M. Bürgle, J. Stürzebecher, S. Sperl, V. Magdolen; The urokinase plasminogen activator system as a novel target for tumor therapy; Fibrinol. Proteol. 2000, 14, 114-132.

448.
B. Muehlenweg, E. Guthaus, N. Arroyo de Prada, M. Schmitt, N. Schmiedeberg, M. Kotzsch, S. Creutzburg, M. D. Kramer, H. Kessler, O. G. Wilhelm, V. Magdolen; Epitope Mapping of Monoclonal Antibodies Directed to PAI-1 Using PAI-1/PAI-2 Chimera and PAI-1-Derived Synthetic Peptides; Thromb. Res. 2000, 98, 73-81.

447.
C. Gibson, H. Kessler; 2-Fluoropyrimidine as an efficient reagent in solid-phase synthesis of N-aryl- and N-alkyl-N-pyrimidin-2-ylamines; Tetrahedron Lett. 2000, 41, 1725-1728.

446.
T. Zhang, X.-A. Mao, M. Baur, H. Kessler; NOESY around the critical point w tc = 1.12. Precise determination of proton-proton distances and reorientation correlation times with two-field NOESY; Mol. Phys. 2000, 98, 201-210.


445.
M. Huenges, H. Kessler; Structural Chemistry Using NMR Spectroscopy, Peptides. - In: Encyclopedia of Spectroscopy and Spectrometry. Eds.: J.C. Lindon, G.E. Trauter, J.L. Holmes; Academic Press Ltd., London, England 1999, 2246-2260.

444.
P. Schaffner, J. Meyer, M. Dard, R. Wenz, B. Nies, S. Verrier, H. Kessler, M. Kantlehner; Induced tissue integration of bone implants by coating with bone selective RGD-peptides in vitro and in vivo studies; Journal of Materials Science: Materials in Medicine 1999, 10, 837-839.

443.
X.-A. Mao, T. Zhang, M. Baur, H. Kessler; Two-field-NOESY for precise determination of proton-proton distances and correlation times; J. Chem. Phys. 1999, 111, 8253-8254.

442.
T. Diercks, M. Coles, H. Kessler; An efficient strategy for assignment of cross-peaks in 3D heteronuclear NOESY experiments; J. Biomol. NMR 1999, 15, 177-180.

441.
M. Koppitz, B. Mathä, H. Kessler; Structure Inverstigation of Amphiphilic Cyclopeptides in Isotropic and Anisotropic Environments - A Model Study Simulating Peptide-Membrane Interactions; J. Peptide Sci. 1999, 5, 507-518.

440.
H. Kessler, R. Konat, M. Kurz, C. Gilon; Conformational Design of Bioactive Peptides. - In: Future Aspects in Peptide Chemistry (Collection Symposium Series Vol. 1) Eds.: W. Voelter, G. Fischer; Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, Prague 1999, 86-94.

439.
M. Coles, T. Diercks, J. Liermann, A. Gröger, B. Rockel, W. Baumeister, K.K. Koretke, A. Lupas, J. Peters, H. Kessler; The solution structure of VAT-N reveals a 'missing link' in the evolution of complex enzymes from a simple ß(ßß element; Current Biology 1999, 9, 1158-1168.

438.
C. Gibson, S. L. Goodman, D. Hahn, G. Hölzemann, H. Kessler; Novel Solid-Phase Synthesis of Azapeptides and Azapeptoids via Fmoc-Strategy and Its Application in the Synthesis of RGD-Mimetics; J. Org. Chem. 1999, 64, 7388-7394.

437.
E. Lohof, F. Burkhart, M. A. Born, E. Planker, H. Kessler; Sugar Amino Acids and Carbohydrates as Scaffolds and Peptidomimetics. - in: Advances in Amino Acid Mimetics and Peptidomimetics (Vol. 2) Ed.: A. Abell; JAI Press Inc., Stanford, Connecticut 1999, 263-292.

436.
D. M. Korzhnev, V. Yu. Orekhov, A. S. Arseniev, R. Gratias, H. Kessler; Mechanism of the Unfolding of Transmembrane (-Helical Segment (1-36)-Bacteriorhodopsin Studied by Molecular Dynamics Simulations; J. Phys. Chem. B 1999, 103, 7036-7043.

435.
V. Yu. Orekhov, D. M. Korzhnev. T. Diercks, H. Kessler, A. S. Arseniev; 1H-15N NMR dynamic study of an isolated (-helical peptide (1-36)-bacteriorhodopsin reveals the equilibrium helix-coil transitions; J. Biomol. NMR 1999, 14, 345-356.

434.
C. Riemer, T. Bayer, H. Kessler; Chiral Pool Derived Synthesis of 2,3-Diaminosuccinic Acid as a Peptidomimetic Building Block. - In: Peptides 1998 (Proc. 25th European Peptide Symposium, Aug. 30 - Sep. 4, 1998, Budapest, Ungarn) Eds.: S. Bajusz, F. Hudecz; Akadémiai Kiadó; Budapest, Ungarn 1999, 690-691.

433.
T. Bayer, C. Riemer, H. Kessler; Synthesis of Orthogonally Protected 2,4-Diaminoglutaric Acid Containing Peptides by Solid Phase Ugi Four Component Condensation. - In: Peptides 1998 (Proc. 25th European Peptide Symposium, Aug. 30 - Sep. 4, 1998, Budapest, Ungarn) Eds.: S. Bajusz, F. Hudecz; Akadémiai Kiadó; Budapest, Ungarn 1999, 652-653.

432.
H. Kessler, M. Bürgle, C. Riemer, V. Magdolen, O. Wilhelm, M. Schmitt; Inhibition of uPA/uPAR-Interaction by Cyclic uPA-Derived Peptides. - In: Peptides 1998 (Proc. 25th European Peptide Symposium, Aug. 30 - Sep. 4, 1998, Budapest, Ungarn) Eds.: S. Bajusz, F. Hudecz; Akadémiai Kiadó; Budapest, Ungarn 1999, 72-73.

431.
H. Kessler, F. Burkhart, M. Koppitz, E. Lohof; Non-natural peptide modifications using sugars and lipophilic side chains. - In: Peptide Science - Present and Future (Proc. 1st International Peptide Symposium, Nov. 30 - Dec. 5, 1997, Kyoto, Japan) Ed.: Y. Shimonishi; Kluwer Academic Publishers; Dordrecht, The Netherlands 1999, 587-594.

430.
G. Hölzemann, S. L. Goodman, C. Rölz, H. Kessler; Cyclic RGD peptides with a novel mimetic. - In: Peptide Science - Present and Future (Proc. 1st International Peptide Symposium, Nov. 30 - Dec. 5, 1997, Kyoto, Japan) Ed.: Y. Shimonishi; Kluwer Academic Publishers, Dordrecht, The Netherlands 1999, 430-431.

429.
O. Mechnich, G. Hessler, M. Bernd, B. Kutscher, H. Kessler; Synthesis and conformational analysis of axinastatin 5 and derivatives. - In: Peptides - Frontiers of Peptide Science (Proc. 15th American Peptide Symposium, June 14-19, 1997, Nashville, Tennessee, USA) Eds.: J. P. Tam, P. T. P. Kaumaya; Kluwer Academic Publishers, Dordrecht, The Netherlands 1999, 465-466.

428.
F. Burkhart, G. Hessler, H. Kessler; Synthesis and conformational analysis of C- and N-glycopeptides. - In: Peptides - Frontiers of Peptide Science (Proc. 15th American Peptide Symposium, June 14-19, 1997, Nashville, Tennessee, USA) Eds.: J. P. Tam, P. T. P. Kaumaya; Kluwer Academic Publishers, Dordrecht, The Netherlands 1999, 449-450.

427.
G. Hölzemann, S.L. Goodman, W. Schmitt, R. Haubner, H. Kessler; From Peptides to Non-Peptides. First Applications with Cyclic RGD Peptides. - In: Proc. 7th Akabori Conference (Japanese-German Symposium on Peptide Chemistry, April 27-30, 1998, Heidelberg, Germany) Ed.: H. Kunz; University Mainz 1998, 62-66.

426.
H. Kessler, M. Schwaiger, M. Bürgle, A. Gröger, M. Coles, M. Lebendiker, H. Yerushalmi, S. Schuldiner; The Multi-Drug-Resistance Protein EmrE - high resolution NMR investigations and secondary structure. - In: Proc. 7th Akabori Conference (Japanese-German Symposium on Peptide Chemistry, April 27-30, 1998, Heidelberg, Germany) Ed.: H. Kunz; University Mainz 1998, 30-35.

425.
M. Coles, T. Diercks, B. Muehlenweg, S. Bartsch, V. Zölzer, H. Tschesche, H. Kessler; The Solution Structure and Dynamics of Human Neutrophil Gelatinase-associated Lipocalin; J. Mol. Biol. 1999, 289, 139-157.

424.
J. Balbach, S. Seip, H. Kessler, M. Scharf, N. Kashani-Poor, J. W. Engels; Structure and Dynamic Properties of the Single Disulfide-Deficient (-Amylase Inhibitor [C45A/C73A]Tendamistat: An NMR Study; Proteins: Structure, Function, and Genetics 1998, 33, 285-294.

423.
J. S. Schmitt, S. L. Goodman, A. Jonczyk, H. Kessler; Synthesis of cyclic RGD-tetra-peptoids and optimization of the submonomer solid phase coupling protocol. - In: Peptides - Frontiers of Peptide Science (Proc. 15th American Peptide Symposium, June 14-19, 1997, Nashville, Tennessee, USA) Eds.: J. P. Tam, P. T. P. Kaumaya; Kluwer Academic Publishers, Dordrecht, The Netherlands 1999, 206-207.

422.
O. Mechnich, G. Hessler, M. Bernd, R. Voegeli, B. Kutscher, H. Kessler; Synthesis and Conformational Analysis of Axinastatin 4. - In: Peptides 1996 (Proc. 24th European Peptide Symposium, September 8-13, 1996, Edinburgh, Scotland) Eds.: R. Ramage, E. Epton; Mayflower Scientific Ltd., England 1998, 629-630.

421.
J. Lutz, R. Romano-Götsch, C. Escrieut, D. Fourmy, B. Mathä, G. Müller, H. Kessler, L. Moroder; Mapping of the Ligand Binding Site of CCK-B/Gastrin Receptor with Lipo-Gastrin Peptides. - In: Peptides 1996 (Proc. 24th European Peptide Symposium, September 8-13, 1996, Edinburgh, Scotland) Eds.: R. Ramage, R. Epton; Mayflower Scientific Ltd., England 1998, 603-604.

420.
H. Kessler, M. Koppitz, B. Mathä; Peptides at Hydrophilic-Lipophilic Interphase. - In: Peptides 1996 (Proc. 24th European Peptide Symposium, September 8-13, 1996, Edinburgh, Scotland) Eds.: R. Ramage, R. Epton; Mayflower Scientific Ltd., England 1998, 535-536.

419.
D. Finsinger, R.K. Konat, W. Schmitt, H. Kessler; Regioselective Thionylation of Tertiary Amide Bonds in Cyclic Tetrapeptides - A Conformational Approach. - In: Peptides 1996 (Proc. 24th European Peptide Symposium, September 8-13, 1996, Edinburgh, Scotland) Eds.: R. Ramage, R. Epton; Mayflower Scientific Ltd., England 1998, 381-382.

418.
M.A. Dechantsreiter, B. Mathä, A. Jonczyk, S.L. Goodman, H. Kessler; Synthesis and Conformational Studies of N-methylated Cyclic RGD-peptides. - In: Peptides 1996 (Proc. 24th European Peptide Symposium, September 8-13, 1996, Edinburgh, Scotland) Eds.: R. Ramage, R. Epton; Mayflower Scientific Ltd., England 1998, 329-330.

417.
D. Besse, S. Pegoraro, T. Diercks, H. Kessler, L. Moroder; Selenocysteine as Useful Device for Selective Disulfide Pairings in Multiple Cysteine Peptides. - In: Peptides 1996 (Proc. 24th European Peptide Symposium, September 8-13, 1996, Edinburgh, Scotland) Eds.: R. Ramage, R. Epton; Mayflower Scientific Ltd., England 1998, 253-254.

416.
M. Kantlehner, D. Finsinger, J. Meyer, P. Schaffner, A. Jonczyk, B. Diefenbach, B. Nies, H. Kessler; Selektive RGD-vermittelte Adhäsion von Osteoblasten an Implantat-Oberflächen; Angew. Chem. 1999, 111, 587-590; Angew. Chem. Int. Ed. 1999, 38, 560-562.

415.
H. Kessler, G. Gemmecker; NMR-Based Modeling of Protein-Protein Complexes and Interaction of Peptides and Proteins with Anisotropic Solvents. - In: NMR in Supramolecular Chemistry (Proc. of the NATO Advanced Workshop on Applications of NMR to the Study of Structure and Dynamics of Supramolecular Complexes, Sitges, Spain, May 5-9, 1998) Ed.: M. Pons; Kluwer Academic Publishers, Dordrecht, The Netherlands (NATO ASI Ser. C, Vol. 526) 1999, 255-266.

414.
F. Burkhart, M. Hoffmann, H. Kessler; C-Glycosides: A Stereoselective Synthesis of a- and ß-C-Galactosides with Glycosyl Dianions; Tetrahedron Lett. 1998, 39, 7699-7702.

413.
M.S. Goligorsky, H. Kessler, V.I. Romanov.; Molecular mimicry of integrin ligation: therapeutic potential of arginine-glycine-aspartic acid (RGD) peptides; Nephrol. Dial. Transplant. 1998, 13, 254-263.

412.
V. Magdolen, S. Albrecht, M. Kotzsch, C. Haller, M. Bürgle, U. Jacob, M. Großer, H. Kessler, H. Graeff, M. Müller, M. Schmitt, T. Luther; Immunological and Functional Analyses of the Extracellular Domain of Human Tissue Factor; Biol. Chem. 1998, 379, 157-165.

411.
M. Huenges, C. Rölz, R. Gschwind, R. Peteranderl, F. Berglechner, G. Richter, A. Bacher, H. Kessler, G. Gemmecker; Solution structure of the antitermination protein NusB of Escherichia coli: a novel all-helical fold for an RNA-binding protein; EMBO J. 1998, 17, 4092-4100.

410.
K. Fischer, V. Lutz, O. Wilhelm, M. Schmitt, H. Graeff, P. Heiss, T. Nishiguchi, N. Harbeck, H. Kessler, T. Luther, V. Magdolen, U. Reuning; Urokinase induces proliferation of human ovarian cancer cells: characterization of structural elements required for growth factor function; FEBS Letters 1998, 438, 101-105.

409.
M. Bachelin, G. Hessler, G. Kurz, J.G. Hacia, P.B. Dervan, H. Kessler; Structure of a stereoregular phosphorothioate DNA/RNA duplex; Nat. Struct. Biol. 1998, 5, 271-276.

408.
S. F. Martin, G. O. Dorsey, T. Gane, M. C. Hillier, H. Kessler, M. Baur, B. Mathä, J. W. Erickson, T. N. Bhat, S. Munshi, S. V. Gulnik, I. A. Topol; Cyclopropane-Derived Peptidomimetics. Design, Synthesis, Evaluation, and Structure of Novel HIV-1 Protease Inhibitors; J. Med. Chem. 1998, 41, 1581-1597.

407.
R. M. Gschwind, G. Gemmecker, H. Kessler; New Multi-quantum Version of the HBHA(CBCACO)NH Experiment with Enhanced Sensitivity for Partially Deuterated Samples; J. Magn. Reson. 1999, 137, 285-288.

406.
R. Haubner, H.-J. Wester, R. Senekowitsch-Schmidtke, B. Diefenbach, H. Kessler, G. Stöcklin, M. Schwaiger; Radiolabeled avß3 Integrin Antagonists: A New Class of Tracers for Tumor Targeting; J. Nucl. Med. 1999, 40, 1061-1071.

405.
M.A. Dechantsreiter, E. Planker, B. Mathä, E. Lohof, G. Hölzemann, A. Jonczyk, S.L. Goodman, H. Kessler; N-Methylated Cyclic RGD Peptides as Highly Active and Selective avß3 Integrin Antagonists; J. Med. Chem. 1999, 42, 3033-3040.

404.
J. Schmitt, M. Bernd, B. Kutscher, H. Kessler; Synthesis of Dolastatin 15 Mimetic Peptoids; Bioorg. & Med. Chem. Lett. 1998, 8, 385-388.

403.
F. Burkhart, H. Kessler; C-Glycosides: A Stereoselective Synthesis of a-C-Galactosamines with a Glycosyl Dianion; Tetrahedron Lett. 1998, 39, 255-256.

402.
M. A. Dechantsreiter, F. Burkhart, H. Kessler; A Stereoselective Synthesis of a C-Glycosylated Peptoid Building Block; Tetrahedron Lett. 1998, 39, 253-254.

401.
C. Gilon, M. Huenges, B. Mathä, G. Gellerman, V. Hornik, M. Afargan, O. Amitay, O. Ziv, E. Feller, A. Gamliel, D. Shohat, M. Wanger, O. Arad, H. Kessler; A Backbone-Cyclic, Receptor 5-Selective Somatostatin Analogue: Synthesis, Bioactivity, and Nuclear Magnetic Resonance Conformational Analysis; J. Med. Chem. 1998, 41, 919-929.

400.
R. M. Gschwind, G. Gemmecker, H. Kessler; A spin labeled and highly resolved ed-H(CCO)NH-TOCSY experiment for the facilitated assignment of proton side chains in partially deuterated samples; J. Biomol. NMR 1998, 11, 191-198.

399.
M. Baur, G. Gemmecker, H. Kessler; 13C-NOESY-HSQC with Split Carbon Evolution for Increased Resolution with Uniformly Labeled Proteins; J. Magn. Reson. 1998, 132, 191-196.

398.
M. Schwaiger, M. Lebendiker, H. Yerushalmi, M. Coles, A. Gröger, C. Schwarz, S. Schuldiner, H. Kessler; NMR investigation of the multidrug transporter EmrE, an integral membrane protein; Eur. J. Biochem. 1998, 254, 610-619.

397.
R. Gratias, R. Konat, H. Kessler, M. Crisma, G. Valle, A. Polese, F. Formaggio, C. Toniolo, Q.B. Broxterman, J. Kamphuis; First Step Towards the Quantitative Identification of Peptide 310-Helix Conformation with NMR Spectroscopy: NMR and X-Ray Diffraction. Structural Analysis of a Fully-Developed 310-Helical Peptide Standard; J. Am. Chem. Soc. 1998, 120, 4763-4770.

396.
R. Gratias, H. Kessler; Molecular Dynamics Study on Microheterogeneity and Preferential Solvation in Methanol/ Chloroform Mixtures; J. Phys. Chem. B 1998, 102, 2027-2031.

395.
M.S. Goligorsky, E. Noiri, H. Kessler, V. Romanov; Therapeutic potential of RGD peptides in acute renal injury; Kidney International 1997, 51, 1487-1492.

394.
M. Baur, H. Kessler; Novel Suppression of the Diagonal Signals in the NOESY Experiment; Magn. Reson. Chem. 1997, 35, 877-882.

393.
V. Romanov, E. Noiri, G. Czerwinski, D. Finsinger, H. Kessler, M.S. Goligorsky; Two novel probes reveal tubular and vascular Arg-Gly-Asp (RGD) binding sites in the ischemic rat kidney; Kidney International 1997, 52, 93-102.

392.
F. Berglechner, G. Richter, M. Fischer, A. Bacher, R.M. Gschwind, M. Huenges, G. Gemmecker, H. Kessler; Studies on the NusB protein of Escherichia coli. Expression and determination of secondary-structure elements by multinuclear NMR spectroscopy; Eur. J. Biochem. 1997, 248, 338-346.

391.
L. Goretzki, J. Bognacki, M. Koppitz, P. Rettenberger, V. Magdolen, S. Creutzburg, J. Hammelburger, U. H. Weidle, O. Wilhelm, H. Kessler, H. Graeff, M. Schmitt; Quantitative assessment of interaction of urokinase-type plasminogen activator and its receptor (CD87) by use of a solid-phase uPA-ligand binding assay; Fibrinolysis & Proteolysis 1997, 11, 11-19.

390.
O. Mechnich, G. Hessler, H. Kessler, M. Bernd, B. Kutscher; Cyclic Heptapeptides Axinastatin 2, 3, and 4: Conformational Analysis and Evaluation of the Biological Potential; Helv. Chim. Acta 1997, 80, 1338-1354.

389.
M. Bürgle, M. Koppitz, C. Riemer, H. Kessler, B. König, U.H. Weidle, J. Kellermann, F. Lottspeich, H. Graeff, M. Schmitt, L. Goretzki, U. Reuning, O. Wilhelm, V. Magdolen; Inhibition of the Interaction of Urokinase-Type Plasminogen Activator (uPA) with Its Receptor (uPAR) by Synthetic Peptides; Biol. Chem. 1997, 378, 231-237.

388.
T. Luther, V. Magdolen, S. Albrecht, M. Kasper, C. Riemer, H. Kessler, H. Graeff, M. Müller, M. Schmitt; Epitope-Mapped Monochloral Antibodies as Tools for Functional and Morphological Analyses of the Human Urokinase Receptor in Tumor Tissue; Amer. J. Pathol. 1997, 150, 1231-1244.

387.
T. Diercks, M. Schwaiger, H. Kessler; HSQC-based Methyl Group Selection via Gradients in Multidimensional NMR Spectroscopy of Proteins; J. Magn. Reson. 1998, 130, 335-340.

386.
M. Hoffmann, H. Kessler; Competition of Deprotonation and Tin-Lithium Exchange in the Generation of a Glycosyl Dianion; Tetrahedron Lett. 1997, 38, 1903-1906.

385.
O. Mechnich, H. Kessler; What are the structures of phakellistatin 2 and phakellistatin 4? Lett. Pept. Sci. 1997, 4, 21-28.

384.
F. Burkhart, M. Hoffmann, H. Kessler; Stereoselektive Synthese eines C-glycosidischen Analogons des N-Glucoasparagins; Angew. Chem. 1997, 109, 1240-1241; Angew. Chem. Int. Ed. Engl. 1997, 36, 1191-1192.

383.
R. Haubner, D. Finsinger, H. Kessler; Stereoisomere Peptid-Bibliotheken und Peptidmimetika zum Design von selektiven Inhibitoren des avß3-Integrins für eine neuartige Krebstherapie; Angew. Chem. 1997, 109, 1440-1456; Angew. Chem. Int. Ed. Engl. 1997, 36, 1374-1389.

382.
H. Kessler; Ein neuartiges Verfahren zur Wirkstoffsuche mit einem kombinatorisch-rationalen Ansatz; Angew. Chem. 1997, 109, 857-859; Angew. Chem. Int. Ed. Engl. 1997, 36, 829-831.

381.
M. Leutner, R.M. Gschwind, J. Liermann, C. Schwarz, G. Gemmecker, H. Kessler; Automated backbone assignment of labeled proteins using the threshold accepting algorithm; J. Biomol. NMR 1998, 11, 31-43.

380.
M. Koppitz, M. Huenges, R. Gratias, H. Kessler, S.L. Goodman, A. Jonczyk; Synthesis of Unnatural Lipophilic N-(9H-Fluoren-9-ylmethoxy)carbonyl-Substituted a-Amino Acids and Their Incorporation into Cyclic RGD-Peptides: A Structure-Activity Study; Helv. Chim. Acta 1997, 80, 1280-1300.

379.
M. Baur, H. Kessler; An Easy Way for Resolution Enhancement in Out-and-Back Triple-Resonance Experiments Applied to the HCACO Sequence; J. Magn. Reson. 1997, 126, 270-273.

378.
R. M. Gschwind, G. Gemmecker, M. Leutner, H. Kessler, R. Gutknecht, R. Lanz, K. Flükiger, B. Erni; Secondary structure of the IIB domain of the Escherichia coli mannose transporter, a new fold in the class of a/ß twisted open-sheet structures; FEBS Lett. 1997, 404, 45-50.

377.
G. Gemmecker, M. Eberstadt, A. Buhr, R. Lanz, S. Golic Grdadolnik, H. Kessler, B. Erni; Glucose Transporter of Escherichia coli: NMR Characterization of the Phosphocysteine Form of the IIBGlc Domain and Its Binding Interface with the IIAGlc Subunit; Biochemistry 1997, 36, 7408-7417.

376.
D. Besse, F. Siedler, T. Diercks, H. Kessler, L. Moroder; Das Redoxpotential von Selenocystin in konformativ nicht eingeschränkten cyclischen Peptiden; Angew. Chem. 1997, 109, 915-917; Angew. Chem. Int. Ed. Engl. 1997, 36, 883-885.

375.
R. Weinkauf, P. Schanen, A. Metsala, E. W. Schlag, M. Bürgle, H. Kessler; Highly Efficient Charge Transfer in Peptide Cations in the Gas Phase: Threshold Effects and Mechanism; J. Phys. Chem. 1996, 100, 18567-18585.

374.
J. Lutz, R. Romano-Götsch, C. Escrieut, D. Fourmy, B. Mathä, G. Müller, H. Kessler, L. Moroder; Mapping of Ligand Binding Sites of the Cholecystokinin-B/Gastrin Receptor with Lipo-Gastrin Peptides and Molecular Modeling; Biopolymers 1997, 41, 799-817.

373.
R.K. Konat, D.F. Mierke, H. Kessler; Conformational Homogeneity and Solvent Effects in Cyclic Peptides. - in: Peptides: Chemistry, Structure and Biology (Proc. of the 14th Am. Pept. Symp., June 18-23, 1995, Columbus, Ohio, USA) Eds.: P.T.P. Kaumaya, R.S. Hodges; Mayflower Scientific Ltd., England 1996, 839-840.

372.
E. Graf von Roedern, E. Lohof, M. Hoffmann, G. Hessler, H. Kessler; Sugar Amino Acids as Novel Peptidomimetics. - In: Peptides: Chemistry, Structure and Biology (Proc. of the 14th American Peptide Symp., June 18-23, 1995, Columbus, Ohio, USA) Eds.: P.T.P. Kaumaya, R.S. Hodges; Mayflower Scientific Ltd., England 1996, 682-684.

371.
R. Haubner, R. Gratias, S.L. Goodman, H. Kessler; RGD plus X: Structure/Activity Investigations on Cyclic RGD-peptides. - In: Peptides: Chemistry, Structure and Biology (Proc. of the 14th American Peptide Symp., June 18-23, 1995, Columbus, Ohio, USA) Eds.: P.T.P. Kaumaya, R.S. Hodges; Mayflower Scientific Ltd., England 1996, 205-206.

370.
M. Koppitz, R. Haeßner, T. Spellig, R. Kahmann, H. Kessler; Synthesis, Activities and Conformational Analysis of Pheromone Derivatives of Ustilago maydis. - In: Peptides: Chemistry, Structure and Biology (Proc. of the 14th American Peptide Symp., June 18-23, 1995, Columbus, Ohio, USA) Eds.: P.T.P. Kaumaya, R.S. Hodges; Mayflower Scientific Ltd., England 1996, 201-202.

369.
L. Käsbeck, H. Kessler; Convenient Syntheses of 2,3,4,6-Tetra- O-alkylated D-Glucose and D-Galactose; Liebigs Ann./Recueil 1997, 169-173.

368.
L. Käsbeck, H. Kessler; Synthesis of S-a-D-Glucosylated L- Cysteine - A Novel S-Glycosyl Amino Acid; Liebigs Ann./Recueil 1997, 165-167.

367.
S. Behrens, B. Mathä, G. Bitan, C. Gilon, H. Kessler; Structure-activity relationship of the ring portion in backbone-cyclic C-terminal hexapeptide analogs of substance P: NMR and molecular dynamics; Int. J. Peptide Protein Res. 1996, 48, 569-578.

366.
M. Hoffmann, F. Burkhart, G. Hessler, H. Kessler; C-Glycoside Analogues of N4-(2-Acetamido-2-deoxy-ß-D-glucopyranosyl)-L-asparagine: Synthesis and Conformational Analysis of a Cyclic C-Glycopeptide; Helv. Chim. Acta 1996, 79, 1519-1532.

365.
J. Wermuth, S.L. Goodman, A. Jonczyk, H. Kessler; Stereoisomerism and Biological Activity of the Selective and Superactive avß3 Integrin Inhibitor cyclo(-RGDfV-) and Its Retro-Inverso Peptide; J. Am. Chem. Soc. 1997, 119, 1328-1335.

364.
M. Kranz, H. Kessler; Novel Synthesis of a Phe-Gly E-Alkene Dipeptide Isostere; Tetrahedron Lett. 1996, 37, 5359- 5362.

363.
O. Mechnich, H. Kessler; Synthesis of Axinastatins 2-5; Tetrahedron Lett. 1996, 37, 5355-5358.

362.
H. Kessler, R.K. Konat, W. Schmitt; Conformational Analysis of Peptides: Application to Drug Design. - in: NMR in Drug Design (CRC Series in Analytical Biotechnology) Ed.: D.J. Craik; CRC Press, Inc., Boca Raton, New York, London, Tokyo; 1996, S. 215-244.

361.
H. Kessler, W. Guba, B. Mathä, M. Koppitz, R. Haeßner, J. Lutz, L. Moroder; Peptides at Hydrophilic-Lipophilic Interphases. - In: The Sixth Akabori Conference (Proc. 6th Akabori Conference, Japanese-German Symposium on Peptide Chemistry, April 17-20, 1996, Ohtsu, Japan) Ed.: Y. Shimonishi; Protein Research Foundation, Osaka, Japan 1996, 172-177.

360.
E. Graf von Roedern, E. Lohof, G. Hessler, M. Hoffmann, H. Kessler; Synthesis and Conformational Analysis of Linear and Cyclic Peptides Containing Sugar Amino Acids; J. Am. Chem. Soc. 1996, 118, 10156-10167.

359.
K. Michael, H. Kessler; MICHAEL-Type Additions in the Synthesis of a-O- and -S-2-Deoxyglycosides; Tetrahedron Lett. 1996, 37, 3453-3456.

358.
M. Eberstadt, S. Golic Grdadolnik, G. Gemmecker, H. Kessler, A. Buhr, B. Erni; Solution Structure of the IIB Domain of the Glucose Transporter of Escherichia coli; Biochemistry 1996, 35, 11286- 11292.

357.
R. Haubner, W. Schmitt, G. Hölzemann, S. L. Goodman, A. Jonczyk, H. Kessler; Cyclic RGD Peptides Containing ß-Turn Mimetics; J. Am. Chem. Soc. 1996, 118, 7881-7891.

356.
M. Koppitz, T. Spellig, R. Kahmann, H. Kessler; Lipoconjugates: structure- aktivity studies for pheromone analogues of Ustilago maydis with varied lipophilicity; Int. J. Peptide Protein Res. 1996, 48, 377-390.

355.
R. Haubner, R. Gratias, B. Diefenbach, S.L. Goodman, A. Jonczyk, H. Kessler; Structural and Functional Aspects of RGD-Containing Cyclic Pentapeptides as Highly Potent and Selective Integrin avß3 Antagonists; J. Am. Chem. Soc. 1996, 118, 7461-7472.

354.
W. Schmitt, G. Zanotti, T. Wieland, H. Kessler; Conformation of Different S- Deoxo-Xaa3-amaninamide-Analogues in DMSO Solution as Determined by NMR-Spectroscopy. Strong CD Effects Induced by ßI,ßII Conformational Change; J. Am. Chem. Soc. 1996, 118, 4380- 4387.

353.
G. Bitan, S. Behrens, B. Mathä, Y. Mashriki, M. Hanani, H. Kessler, C. Gilon; New backbone cyclic substance P analogs; Lett. Pept. Sci. 1995, 2, 121-124.

352.
V. Magdolen, P. Rettenberger, M. Koppitz, L. Goretzki, H. Kessler, U.H. Weidle, B. König, H. Graeff, M. Schmitt, O. Wilhelm; Systematic mutational analysis of the receptor-binding region of the human urokinase- type plasminogen activator; Eur. J. Biochem. 1996, 237, 743-751.

351.
E. Lioy, H. Kessler; Synthesis of a New Chiral Peptide Analogue of DNA Using Ornithine Subunits and Solid-Phase Peptide Synthesis Methodologies; Liebigs Ann. 1996, 201-204.

350.
H. Kessler, B. Diefenbach, D. Finsinger, A. Geyer, M. Gurrath, S. L. Goodman, G. Hölzemann, R. Haubner, A. Jonczyk, G. Müller, E. Graf von Roedern, J. Wermuth; Design of superactive and selective integrin receptor antagonists containing the RGD sequence; Lett. Pept. Sci. 1995, 2, 155-160.

349.
B. Kutscher, M. Bernd, T. Beckers, T. Klenner, E. E. Polymeropoulos, J. Engel, A. Kleemann, M. Bachelin, T. Diercks, H. Kessler; Synthetic Peptides as Ligands for the Characterization of the Human LHRH-Receptor. - in: The Sixth Akabori Conference (Proc. 6th Akabori Conference, Japanese-German Symposium on Peptide Chemistry, April 17-20, 1996, Ohtsu, Japan) Ed.: Y. Shimonishi; Protein Research Foundation, Osaka, Japan 1996, 127-132.

348.
K. Michael, V. Wittmann, W. König, J. Sandow, H. Kessler; S- and C- glycopeptide derivatives of an LH-RH agonist; Int. J. Peptide Protein Res. 1996, 48, 59-70.

347.
H. Kessler, R. Gratias, G. Hessler, M. Gurrath, G. Müller; Conformation of cyclic peptides. Principle concepts and the design of selectivity and superactivity in bioactive sequences by "spatial screening"; Pure & Appl. Chem. 1996, 68, 1201-1205.

346.
D. Besse, S. Pegoraro, T. Diercks, H. Kessler, L. Moroder; Controlled Disulfide Bridging in Multiple Cysteine-Containing Peptides with Built-In Selenocysteines. - in: The Sixth Akabori Conference (Proc. 6th Akabori Conference, Japanese-German Symposium on Peptide Chemistry, April 17- 20, 1996, Ohtsu, Japan) Ed.: Y. Shimonishi; Protein Research Foundation, Osaka, Japan 1996, 24-29.

345.
J. Wermuth, S. Goodman, H. Kessler; Conformational differences of cyclic RGD-peptides and their retro-inverso isomers: The effect on antiadhesive activities. - in: Peptides 1994 (Proc. of the 23rd European Peptide Symposium, Sept. 4-10, 1994, Braga, Portugal) Ed.: H.L.S. Maia, ESCOM, Leiden 1995, 648-649.

344.
R.K. Konat, S. Golic Grdadolnik, W. Schmitt, H. Kessler; Conformational studies on cyclic tetrapeptides: Hydrophobic cluster formation. - in: Peptides 1994 (Proc. of the 23rd European Peptide Symposium, Sept. 4-10, 1994, Braga, Portugal) Ed.: H.L.S. Maia, ESCOM, Leiden 1995, 521-522.

343.
O. Frey, M. Hoffmann, H. Kessler; Stereoselektive Synthese von Retro- Isomeren des N-Glucoasparagins; Angew. Chem. 1995, 107, 2194-2195; Angew. Chem. Int. Ed. Engl. 1995, 34, 2026-2028.

342.
G. Gemmecker, H. Kessler; Methodology and Applications of Heteronuclear and Multidimensional 13C NMR to the Elucidation of Molecular Structure and Dynamics in the Liquid State. - in: Carbon-13 NMR Spectroscopy of Biological Systems. Hrsg.: N. Beckmann, Academic Press, Inc. 1995, 7-64.

341.
H. Kessler, E. Graf von Roedern, E. Lohof, R. Haubner, A. Geyer, V. Wittmann; New Peptidomimetics and Conformational Consequences. - in: 5th Akabori Conference (Proc. of the 5th Akabori Conference, German-Japanese Symposium on Peptide Chemistry, Dresden, May 8-12, 1994) Hrsg.: E. Wünsch, Max-Planck-Gesellschaft, Germany 1994, 110-115.

340.
R.K. Konat, B. Mathä, J. Winkler, H. Kessler; Axinastatin 1 or Malaysiatin? Proof of Constitution and 3D Structure in Solution of a Cyclic Heptapeptide with Cytostatic Properties; Liebigs Ann. 1995, 765-774.

339.
H. Kessler, W. Schmitt; Peptides & Polypeptides. - in: Encyclopedia of Nuclear Magnetic Resonance. Vol. 6. Eds.: D. M. Grant, R. K. Harris; John Wiley & Sons, Ltd., Chichester, 1996, 3527-3537.

338.
H. Kessler; Dynamics by NMR. - in: Encyclopedia of Nuclear Magnetic Resonance. Vol. 1 (Historical Perspectives) Eds.: D. M. Grant, R. K. Harris; John Wiley & Sons, Ltd., Chichester 1996, 424-425.

337.
O. Frey, M. Hoffmann, V. Wittmann, H. Kessler, P. Uhlmann, A. Vasella; Preparation and Transmetallation of a Triphenylstannyl ß-D- Glucopyranoside: A Highly Stereoselective Route to ß-D-C-Glycosides via Glycosyl Dianions; Helv. Chim. Acta 1994, 77, 2060- 2069.

336.
H. Matter, H. Kessler; Structures, Dynamics and Biological Activities of 15 Cyclic Hexapeptide Analogs of the a-Amylase Inhibitor Tendamistat (HOE 467) in Solution; J. Am. Chem. Soc. 1995, 117, 3347- 3359.

335.
E. Noiri, J. Gailit, D. Sheth, H. Magazine, M. Gurrath, G. Müller, H. Kessler, M. S. Goligorsky; Cyclic RGD peptides ameliorate ischemic acute renal failure in rats; Kidney International 1994, 46, 1050-1058.

334.
H. Kessler, M. Eberstadt, W. Schmitt; Multidimensional NMR Spectroscopy of Proteins. in: NMR of Biological Macromolecules. Ed.: C. I. Stassinopoulou; NATO ASI Series, Vol. H 87; Springer-Verlag, Berlin 1994, S. 171-188.

333.
W. Jahnke, M. Baur, G. Gemmecker, H. Kessler; Improved Accuracy of NMR Structures by a Modified NOESY-HSQC Experiment; J. Magn. Reson. 1995, 106 B, 86-88.

332.
W. Jahnke, H. Kessler; Modifizierte Tripelresonanz-NMR- Experimente mit erhöhter Empfindlichkeit für schnell austauschende Protonen; Angew. Chem. 1995, 107, 536-538; Angew. Chem. Int. Ed. Engl. 1995, 34, 469-471.

331.
M. Eberstadt, W. Guba, H. Kessler, H. Kogler, D.F. Mierke; Conformation and Dynamics of Dimeric Ureido-Balhimycin; Biopolymers 1995, 36, 429-437.

330.
H. Matter, G. Gemmecker, H. Kessler; Influence of Serine in Position i on Conformation and Dynamics of Reverse Turns; Int. J. Peptide Protein Res. 1995, 45, 430-440.

329.
M. Eberstadt, G. Gemmecker, D.F. Mierke, H. Kessler; Skalare Kopplungen - ihre Analyse und ihre Verwendung zur Strukturaufklärung; Angew. Chem. 1995, 107, 1813-1838; Angew. Chem. Int. Ed. Engl. 1995, 34, 1671-1695.

328.
M. Hoffmann, H. Kessler; A Stereoselective Synthesis of 2-Acetamido-2- deoxy-C-glucosides: Glycosyl Dianions as Key Intermediates; Tetrahedron Lett. 1994, 35, 6067-6070.

327.
W. Jahnke, H. Kessler; Enhanced sensitivity of rapidly exchanging amide protons by improved phase cycling and the constructive use of radiation damping; J. Biomol. NMR 1994, 4, 735-740.

326.
J. Balbach, H. Kessler; 13C-Edited Double-Quantum Spectroscopy of Peptides and Proteins; J. Magn. Reson. 1994, 105B, 83-87.

325.
G. Müller, M. Gurrath, H. Kessler; Pharmacophore refinement of gpIIb/IIIa antagonists based on comparative studies of antiadhesive cyclic and acyclic RGD peptides; J. Comp-Aided Mol. Design 1994, 8, 709-730.

324.
H. Kessler, K. Michael, M. Kottenhahn; TMS Triflate-Promoted O- Glycosylation of Amino Acids and Peptides by L-Acosaminal and L- Ristosaminal; Liebigs Ann. Chem. 1994, 811-816.

323.
M. Pfaff, K. Tangemann, B. Müller, M. Gurrath, G. Müller, H. Kessler, R. Timpl, J. Engel; Selective Recognition of Cyclic RGD Peptides of NMR Defined Conformation by aIIbß3, aVß3 and a5ß1 Integrins. J. Biol. Chem. 1994, 269, 20233-20238.

322.
W. Guba, R. Haeßner, G. Breipohl, S. Henke, J. Knolle, V. Santagada, H. Kessler; A Novel Combined Approach of NMR and Molecular Dynamics within a Biphasic Membrane Mimetic: Conformation and Orientation of the Bradykinin Antagonist Hoe 140; J. Am. Chem. Soc. 1994, 116, 7532-7540.

321.
A. Geyer, G. Müller, H. Kessler; Conformational Analysis of a Cyclic RGD Peptide Containing a y[CH2-NH] Bond: A Positional Shift in Backbone Structure Caused by a Single Dipeptide Mimetic; J. Am. Chem. Soc. 1994, 116, 7735-7743.

320.
R. Haubner, M. Gurrath, G. Müller, M. Aumailley, H. Kessler; Synthetic peptides for the inhibition of cell-cell and cell-matrix adhesion. - in: Prospects in Diagnosis and Treatment of Breast Cancer (Proc. of the Joint International Symposium on Prospects in Diagnosis and Treatment of Breast Cancer, 10-11 November 1993, Munich, Germany) Eds.: M. Schmitt, H. Graeff, G. Kindermann; International Congress Series No. 1050: Excerpta Medica; Elsevier Science B.V. Amsterdam 1994, 133-143.

319.
S. Golic Grdadolnik, D.F. Mierke, G. Byk, I. Zeltser, C. Gilon, H. Kessler; Comparison of the Conformation of Active and Nonactive Backbone Cyclic Analogs of Substance P as a Tool to Elucidate Features of the Bioactive Conformation: NMR and Molecular Dynamics in DMSO and Water; J. Med. Chem. 1994, 37, 2145-2152.

318.
E. Graf von Roedern, H. Kessler; Eine Zuckeraminosäure als neuartiges Peptidmimetikum; Angew. Chem. 1994, 106, 684-686; Angew. Chem. Int. Ed. Engl. 1994, 33, 687-689.

317.
S. Seip, J. Balbach, S. Behrens, H. Kessler, K. Flükiger, R. de Meyer, B. Erni; Mannose Transporter of Escherichia coli. Backbone Assignments and Secondary Structure of the IIA Domain of the IIABMan Subunit; Biochemistry 1994, 33, 7174-7183.

316.
D. F. Mierke, A. Geyer, H. Kessler; Coupling constants and hydrogen bonds as experimental restraints in a distance geometry refinement protocol; Int. J. Pept. Protein Res. 1994, 44, 325-331.

315.
S. Golic Grdadolnik, M. Eberstadt, G. Gemmecker, H. Kessler, A. Buhr, B. Erni; The glucose transporter of Escherichia coli. Assignment of the 1H, 13C and 15N resonances and identification of the secondary structure of the soluble IIB domain; Eur. J. Biochem. 1994, 219, 945-952.

314.
W. Jahnke, D.F. Mierke, L. Béress, H. Kessler; Structure of Cobra Cardiotoxin CTXI as Derived from NMR Spectroscopy and Distance Geometry Calculations, J. Mol. Biol. 1994, 240, 445-458.

313.
D.F. Mierke, T. Huber, H. Kessler; Coupling constants again: Experimental restraints in structure refinement: J. Comp.-Aided Mol. Des. 1994, 8, 29-40.

312.
L. Moroder, R. Romano, W. Guba, D.F. Mierke, H. Kessler, C. Delporte, J. Winand, J. Christophe; New Evidence for a Membrane-Bound Pathway in Hormone Receptor Binding, Biochemistry 1993, 32, 13551-13559.

311.
W. Guba, H. Kessler; A Novel Computational Mimetic of Biological Membranes in Molecular Dynamics Simulations; J. Phys. Chem. 1994, 98, 23-27.

310.
S. Seip, J. Balbach, H. Kessler; Determination of Backbone Conformation of Isotopically Enriched Proteins Based on Coupling Constants; J. Magn. Reson. 1994, B 104, 172-179.

309.
M. Köck, G. Müller, H. Kessler; Computational Approach to the Receptor-Bound Conformation of Cyclosporin A; Helv. Chim. Acta 1994, 77, 171-181.

308.
L. Moroder, R. Romano, J. Winand, J. Christophe, W. Guba, D.F. Mierke, H. Kessler; A comparative study on the physical and conformational state of double-tailed lipo-gastrin and -CCK derivatives. - in: Peptides: Chemistry, Structure and Biology (Proc. of the 13th American Peptide Symposium, June 20-25, 1993, Edmonton, Alberta, Canada) Hrsg.: R.S. Hodges, J.A. Smith; ESCOM Science Publishers, Leiden, The Netherlands 1994, 493-495.

307.
D. F. Mierke, H. Kessler; Solvent simulations and internal motions. - in: Peptides: Chemistry, Structure and Biology (Proc. of the 13th American Peptide Symposium, June 20-25, 1993, Edmonton, Alberta, Canada) Hrsg.: R. S. Hodges, J. A. Smith; ESCOM Science Publishers, Leiden, The Netherlands 1994, 902-904.

306.
D. F. Mierke, H. Kessler; Peptide structures from NMR. - in: Peptides: Chemistry, Structure and Biology (Proc. of the 13th American Peptide Symposium, June 20-25, 1993, Edmonton, Alberta, Canada) Hrsg.: R. S. Hodges, J. A. Smith; ESCOM Science Publishers, Leiden, The Netherlands 1994, 1096-1098.

305.
D. F. Mierke, R. M. Scheek, H. Kessler; Coupling Constants as Restraints in Ensemble Distance Driven Dynamics; Biopolymers 1994, 34, 559-563.

304.
G. Gemmecker, W. Jahnke, H. Kessler; Measurement of Fast Proton Exchange Rates in Isotopically Labeled Compounds; J. Am. Chem. Soc. 1993, 115, 11620-11621.

303.
D. F. Mierke, H. Kessler; Simple modifications of MD force fields for determination of peptide structures from NMR data; in: Trends in QSAR and Molecular Modelling 1992 (Proc. of the 9th European Symposium on Structure-Activity Relationships: QSAR and Molecular Modelling; Sept. 7-11, 1992, Strasbourg, France) Ed.: C.G. Wermuth; ESCOM Science Publishers, Leiden, The Netherlands 1993, 59-66.

302.
W. Schüler, U. Christians, P. Schmieder, H.-M. Schiebel, I. Holze, K.-F. Sewing, H. Kessler; Structural Investigations of 13-O-Demethyl-FK506 and Its Isomers Generated by in vitro Metabolism of FK506 Using Human- Liver Microsomes; Helv. Chim. Acta 1993, 76, 2288- 2302.

301.
D.F. Mierke, M. Kurz, H. Kessler; Peptide Flexibility and Calculations of an Ensemble of Molecules; J. Am. Chem. Soc. 1994, 116, 1042-1049.

300.
A.H. van Oijen, S. Behrens, D.F. Mierke, H. Kessler, J.H. van Boom, R.M.J. Liskamp; Synthesis and Structure of Cyclic Phosphopeptides Containing a Phosphodiester Linkage; J. Org. Chem. 1993, 58, 3722-3730.

299.
V. Wittmann, H. Kessler; Stereoselektive Synthese von C-Glycosiden mit einem Glycosyl-Dianion; Angew. Chem. 1993, 105, 1138-1140; Angew. Chem. Int. Ed. Engl. 1993, 32, 1091-1093.

298.
H. Kessler; Peptoide - Schlüsselverbindungen für einen neuen Weg zur Entwicklung von pharmazeutischen Wirkstoffen; Angew. Chem. 1993, 105, 572-573; Angew. Chem. Int. Ed. Engl. 1993, 32, 543-544.

297.
H. Kessler, H. Matter, G. Gemmecker, H.-J. Diehl, C. Isernia, S. Mronga; The pseudo-ßI-turn. A new structural motif with a cis peptide bond in cyclic hexapeptides; Int. J. Peptide Protein Res. 1994, 43, 47-61.

296.
R. K. Konat, D. F. Mierke, H. Kessler, B. Kutscher, M. Bernd, R. Voegeli; Synthesis and Solvent Effects on the Conformation of Hymenistatin 1; Helv. Chim. Acta 1993, 76, 1649-1666.

295.
S. Zimmer, E. Hoffmann, G. Jung, H. Kessler; 'Head-to-Tail' Cyclization of Hexapeptides Using Different Coupling Reagents; Liebigs Ann. Chem. 1993, 497-501.

294.
M. Gerz, H. Matter, H. Kessler; Synthesis and solution structure of an S- glycosylated cyclic hexapeptide. Evidence for conformational change induced by glycosylation; Int. J. Peptide Protein Res. 1994, 43, 248-257.

293.
L. Moroder, H.-J. Musiol, K. Köcher, J. P. Bali, C. H. Schneider, W. Guba, G. Müller, D. F. Mierke, H. Kessler; Synthetic immunogens. The effect of the conformational space on biological and immunological responses to dimeric hormone constructs; Eur. J. Biochem. 1993, 212, 325-333.

292.
H. Kessler, D. F. Mierke; Conformational Analysis in Solution of Antibiotics with Immunosuppressive Activity. - in: Antibiotics and Antiviral Compounds - Chemical Synthesis and Modification, Hrsg.: K. Krohn, H. A. Kirst, H. Maag; VCH Verlagsgesellschaft, Weinheim 1993, 241-250.

291.
A. Geyer, D. F. Mierke, C. Unverzagt, H. Kessler; Synthesis of cyclic thiohexapeptides. - in: Peptides 1992 (s.o.) Hrsg.: C.H. Schneider, A.N. Eberle; ESCOM Science Publishers, Leiden, The Netherlands, 1993, 599-600.

290.
M. Köck, G. Müller, H. Kessler; Structure-activity relationship of cyclosporin A using dynamic forcing. - in: Peptides 1992 (s.o.) Hrsg.: C.H. Schneider, A.N. Eberle; ESCOM Science Publishers, Leiden, The Netherlands, 1993, 511-512.

289.
S. Zimmer, E. Hoffmann, G. Jung, H. Kessler; Synthesis and backbone cyclization studies of hexapeptides using the reagents TBTU, HBTU, DPPA, and PPA. - in: Peptides 1992 (s.o.) Hrsg.: C.H. Schneider, A.N. Eberle; ESCOM Science Publishers, Leiden, The Netherlands, 1993, 393- 394.

288.
V. Wittmann, H. Kessler; Synthesis of C-glycosyl amino acids and their use in SPPS. - in: Peptides 1992 (s.o.) Hrsg.: C.H. Schneider, A.N. Eberle; ESCOM Science Publishers, Leiden, The Netherlands, 1993, 369- 370.

287.
H. Kessler, M. Gurrath, G. Müller, M. Aumailley, R. Timple; Selective RGD peptides for inhibition of cell-cell interactions via backbone cyclization. - in: Peptides 1992 (Proc. of the 22nd European Peptide Symposium, Interlaken, Switzerland, September 13-19, 1992) Hrsg.: C.H. Schneider, A.N. Eberle; ESCOM Science Publishers, Leiden, The Netherlands, 1993, 75-76.

286.
S. Seip, J. Balbach, H. Kessler; A simple way for sequential assignment in isotopically enriched proteins using a H(N)CACO correlation; J. Biomol. NMR 1993, 3, 233-237.

285.
S. Seip, J. Balbach, H. Kessler; Bestimmung der HN-Ha Kopplungskonstanten in großen, isotopenmarkierten Proteinen; Angew. Chem. 1992, 104, 1656-1658; Angew. Chem. Int. Ed. Engl. 1992, 31, 1609-1611.

284.
M. Eberstadt, D. F. Mierke, M. Köck, H. Kessler; Peptide Conformation from Coupling Constants: Scalar Couplings as Restraints in MD Simulations; Helv. Chim. Acta 1992, 75, 2583- 2592.

283.
D. F. Mierke, H. Kessler; Improved Molecular Dynamics Simulations for the Determination of Peptide Structures; Biopolymers 1993, 33, 1003-1017.

282.
M. Gerz, H. Matter, H. Kessler; S-glycosylierte Cyclopeptide; Angew. Chem. 1993, 105, 311-313; Angew. Chem. Int. Ed. Engl. 1993, 32, 269-271.

281.
M. Gurrath, G. Müller, H. Kessler, M. Aumailley, R. Timpl; Conformation/activity studies of rationally designed potent anti-adhesive RGD peptides; Eur. J. Biochem. 1992, 210, 911- 921.

280.
A. E. Torda, R. M. Brunne, T. Huber, H. Kessler, W. F. van Gunsteren; Structure refinement using time-averaged J-coupling constants restraints; J. Biomol. NMR 1993, 3, 55-66.

279.
H. Kessler, R. Haessner, W. Schüler; Structure of Rapamycin: An NMR and Molecular-Dynamics Investigation; Helv. Chim. Acta 1993, 76, 117-130.

278.
P. Schmieder, J. H. Ippel, H. van den Elst, G. A. van der Marel, J. H. van Boom, C. Altona, H. Kessler; Heteronuclear NMR of DNA with the heteronucleus in natural abundance: Facilitated assignment and extraction of coupling constants; Nucleic Acids Res. 1992, 20, 4747-4751.

277.
H. Kessler, S. Seip; NMR of Peptides - in: Two-Dimensional NMR Spectroscopy: Applications for Chemists and Biochemists (Eds.: W.R. Croasmun, R.M.K. Carlson) VCH Publishers, New York, 1994, 619- 654.

276.
H. Kessler; Struktur und Design von Cyclopeptiden zur Regulation des Immunsystems; J. prakt. Chem. 1992, 334, 549- 557.

275.
D. F. Mierke, S. Golic Grdadolnik, H. Kessler; Use of One Bond Ca-Ha Coupling Constants As Restraints in MD Simulations; J. Am. Chem. Soc. 1992, 114, 8283-8284.

274.
S. Seip, J. Balbach, H. Kessler; An Improved Technique for Correlating Backbone Amide Protons with 15N and Ha Protons (HN(CA)H) in Isotopically Enriched Proteins; J. Magn. Reson. 1992, 100, 406-410.

273.
C. Unverzagt, A. Geyer, H. Kessler; Racemisierungsfreie Kettenverlängerung von Thiodipeptiden mit Proteasen; Angew. Chem. 1992, 104, 1231-1233; Angew. Chem. Int. Ed. Engl. 1992, 31, 1229-1230.

272.
G. Müller, M. Gurrath, M. Kurz, H. Kessler; ßVI Turns in Peptides and Proteins. A Model Peptide Mimicry; Proteins: Structure, Function, and Genetics 1993, 15, 235-251.

271.
H. Kessler, V. Wittmann, M. Köck, M. Kottenhahn; Synthese von C-Glycopeptiden durch radikalische Addition von Glycosylbromiden an Dehydroalaninderivate; Angew. Chem. 1992, 104, 874-877; Angew. Chem. Int. Ed. Engl. 1992, 31, 902-904.

270.
D.F. Mierke, H. Dürr, H. Kessler, G. Jung; Neuropeptide Y: Optimized Solid Phase Synthesis and Conformational Analysis in Trifluoroethanol; Eur. J. Biochem. 1992, 206, 39-48.

269.
D.F. Mierke, H. Kessler; Combined Use of Homo- and Heteronuclear Coupling Constants as Restraints in Molecular Dynamics Simulations; Biopolymers 1992, 32, 1277-1282.

268.
H. Kessler, H. Matter, A. Geyer, H.-J. Diehl, M. Köck, G. Kurz, F.R. Opperdoes, M. Callens, R.K. Wierenga; Selektive Inhibierung der trypanosomalen Triosephosphat-Isomerase durch ein Thiopeptid; Angew. Chem. 1992, 104, 343-345; Angew. Chem. Int. Ed. Engl. 1992, 31, 328-330.

267.
L. Moroder, K. Köcher, H.-J. Musiol, W. Guba, G. Müller, H. Kessler; The Conformational Space of Conjugated Peptide Hormones Affects Critically Their Bioactivity and Immunoreactivity; - in: The Fourth Akabori Conference (Proc. of the 4th Akabori Conference, Japanese-German Symposium on Peptide Chemistry, Shizuoka/Japan, Oct. 7-10, 1991) (Hrsg.: N. Yanaihara, E. Wünsch) Protein Research Foundation, Osaka, Japan, 1992, 191-200.

266.
M. Gurrath, G. Müller, H. Kessler, R. Timpl, M. Aumailley; Structure and Conformation-Activity Studies Leading to Potent RGD Containing Vitronectin and Laminin P1 Antagonists; - in: s. Nr. 265. Verlag Mainz, Aachen, DWI Reports, 1993, 112A, 489-498.

265.
G. Müller, M. Gurrath, H. Kessler, R. Timpl, M. Aumailley; Conformational Analysis and Structure-Activity Relationships of Bioactive RGD (Arg-Gly-Asp) Peptides. A Computational Approach; - in: Chemistry of Peptides and Proteins (Vol. 5/6) (Proc. 7th USSR-FRG Symp. on Chemistry of Peptides and Proteins, Dilizhan, USSR, Sept. 23-30, 1989 and 8th FRG-USSR Symp. Aachen, FRG, 29.9.-3.10.1991) Hrsg.: D. Brandenburg, V. Ivanov, W. Voelter; Verlag Mainz, Aachen, DWI Reports, 1993, 112A, 499-511.

264.
G. Müller, M. Gurrath, H. Kessler, R. Timpl; "Dynamischer Zwang", eine Hilfe für das Verständnis der Aktivität und Selektivität von RGD(Arg-Gly-Asp)-Peptiden; Angew. Chem. 1992, 104, 341-343; Angew. Chem. Int. Ed. Engl. 1992, 31, 326-328.

263.
H. Kessler, A. Geyer, H. Matter, M. Köck; Unusual Thionation of a Cyclic Hexapeptide. Conformational Changes and Dynamics; Int. J. Pept. Prot. Res. 1992, 40, 25-40.

262.
M. Köck, H. Kessler, D. Seebach, A. Thaler; Novel Backbone Conformation of Cyclosporin A: The Complex with Lithium Chloride; J. Am. Chem. Soc. 1992, 114, 2676-2686.

261.
M. Kurz, D.F. Mierke, H. Kessler; Moleküldynamikrechnungen für Peptide in Dimethylsulfoxid: Eliminierung von Vakuumeffekten; Angew. Chem. 1992, 104, 213-214; Angew. Chem. Int. Ed. Engl. 1992, 31, 210-212.

260.
H. Kessler, S. Mronga, B. Kutscher, A. Müller, W.S. Sheldrick; Synthesis of the 4-Pyridine Analog of Kostanecki's Triketone. Determination of Constitution and Stereochemistry by 2D-NMR Spectroscopy and X-ray Structural Analysis; Liebigs Ann. Chem. 1991, 1337-1341.

259.
D. Seebach, S.Y. Ko, H. Kessler, M. Köck, M. Reggelin, P. Schmieder, M.D. Walkinshaw, J.J. Bölsterli, D. Bevec; Thiocyclosporins: Preparation, Solution and Crystal Structure, and Immunosuppressive Activity; Helv. Chim. Acta 1991, 74, 1953-1990.

258.
M. Aumailley, M. Gurrath, G. Müller, J. Calvete, R. Timpl, H. Kessler; Arg-Gly-Asp constrained within cyclic pentapeptides: strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1; FEBS Lett. 1991, 291, 50-54.

257.
H. Kessler, D.F. Mierke, J. Saulitis, S. Seip, S. Steuernagel, T. Wein, M. Will; The Structure of Ro 09-0198 in Different Environments; Biopolymers 1992, 32, 427-433.

256.
P. Schmieder, H. Kessler; Determination of the f Angle in a Peptide Backbone by NMR Spectroscopy with a Combination of Homonuclear and Heteronuclear Coupling Constants; Biopolymers 1992, 32, 435-440.

255.
M. Kurz, P. Schmieder, H. Kessler; HETLOC, eine effiziente Methode zur Bestimmung heteronuclearer Weitbereichskopplungen mit dem Heterokern in natürlicher Häufigkeit; Angew. Chem. 1991, 103, 1341-1342; Angew. Chem. Int. Ed. Engl. 1991, 30, 1329-1331.

254.
H. Kessler, B. Haase; Cyclic hexapeptides derived from the human thymopoietin III; Int. J. Pept. Prot. Res. 1992, 39, 36-40.

253.
H. Kessler, S. Seip, T. Wein, S. Steuernagel, M. Will; Structure of cinnamycin (Ro 09-0198) in solution; - in: Nisin and Novel Lantibiotics (Proc. 1th Int. Workshop on Latibiotics, April 1991, Bad Honnef) (Hrsg: G. Jung, H.G. Sahl) ESCOM, Leiden, 1991, 76-90.

253.
G. Bitan, S. Behrens, B. Mathä, Y. Mashriki, M. Hanani, H. Kessler, C. Gilon; New backbone cyclic substance P analogs; Lett. Pept. Sci. 1995, 2, 121-124.

252.
D.F. Mierke, P. Schmieder, P. Karuso, H. Kessler; Conformational Analysis of the cis- and trans-Isomers of FK 506 by NMR and Molecular Dynamics; Helv. Chim. Acta 1991, 74, 1027-1047.

251.
P. Schmieder, M. Kurz, H. Kessler; Determination of heteronuclear long-range couplings to heteronuclei in natural abundance by two- and three-dimensional NMR spectroscopy; J. Biomol. NMR 1991, 1, 403-420.

250.
H. Kessler, D.F. Mierke, D. Donald, M. Furber; Auf dem Weg zum Verständnis der Immunsuppression; Angew. Chem. 1991, 103, 968-969; Angew. Chem. Int. Ed. Engl. 1991, 30, 954-955.

249.
J. Saulitis, D.F. Mierke, G. Byk, C. Gilon, H. Kessler; Conformation of Cyclic Analogues of Substance P: NMR and Molecular Dynamics in Dimethyl Sulfoxide; J. Am. Chem. Soc. 1992, 114, 4818-4827.

248.
H. Kessler, H. Matter, G. Gemmecker, M. Kottenhahn, J.W. Bats; Structure and Dynamics of a Synthetic O-Glycosylated Cyclopeptide in Solution Determined by NMR Spectroscopy and MD Calculations; J. Am. Chem. Soc. 1992, 114, 4805-4818.

247.
D.A. Kuntz, R. Osowski, M. Schudok, R.K. Wierenga, K. Müller, H. Kessler, F.R. Opperdoes; Inhibition of triosephosphate isomerase from Trypanosoma brucei with cyclic hexapeptides; Eur. J. Biochem. 1992, 207, 441-447.

246.
W. Guba, G. Müller, H. Kessler; Rational drug design via molecular dynamics simulations of HIV-1 protease inhibitor complexes; J. Chim. Phys. 1991, 88, 2551-2556.

245.
D.F. Mierke, H. Kessler; Molecular Dynamics with Dimethyl Sulfoxide as a Solvent. Conformation of a Cyclic Hexapeptide; J. Am. Chem. Soc. 1991, 113, 9566-9470.

244.
H. Kessler, S. Mronga, G. Gemmecker; Multi-Dimensional NMR Experiments Using Selective Pulses; Magn. Reson. Chem. 1991, 29, 527-557.

243.
H. Kessler, S. Mronga, G. Müller, L. Moroder, R. Huber; Conformational Analysis of a IgG1 Hinge Peptide Derivative in Solution Determined by NMR Spectroscopy and Refined by Restrained Molecular Dynamics Simulations; Biopolymers 1991, 31, 1189-1204.

242.
H. Kessler, H. Matter, G. Gemmecker, A. Kling, M. Kottenhahn; Solution Structure of a Synthetic N-Glycosylated Cyclic Hexapeptide Determined by NMR Spectroscopy and MD Calculations; J. Am. Chem. Soc. 1991, 113, 7550-7563.

241.
M. Kottenhahn, H. Kessler; Synthese von 2-Desoxy-a-O-glycopeptiden mit dem N-Iodsuccinimid-(NIS-)Verfahren; Liebigs Ann. Chem. 1991, 727-744.

240.
H. Kessler, S. Seip, J. Saulitis; Determination of cross relaxation rates by 3D NOE-NOE spectroscopy; J. Biomol. NMR 1991, 1, 83-92.

239.
P. Schmieder, T. Domke, D.G. Norris, M. Kurz, H. Kessler, D. Leibfritz; Editing of Multiplicity in Two- and Three-Dimensional Heteronuclear NMR Spectroscopy by Fourier Transformation of the Pulse-Angle Dependency; J. Magn. Reson. 1991, 33, 430-435.

238.
P. Schmieder, S. Zimmer, H. Kessler; Increased Resolution in Proton Detected Heteronuclear NMR Experiments by Folding in the Hetero-Dimension; Magn. Reson. Chem.1991, 29, 375-380.

237.
H. Kessler, T. Wein; Solution Structure of Phalloidin Obtained by NMR Spectroscopy in [D6]DMSO and Molecular Dynamics Calculation in Vacuo and in Water; Liebbigs Ann. Chem. 1991, 179-184.

236.
H. Kessler, M. Köck, T. Wein, M. Gehrke; Reinvestigation of the Conformation of Cyclosporin A in Chloroform; Helv. Chim. Acta 1990, 73, 1818-1832.

235.
P. Karuso, H. Kessler, D.F. Mierke; Solution Structure of FK 506 from NMR and Molecular Dynamics; J. Am. Chem. Soc. 1990, 112, 9434-9436.

234.
H. Kessler, P. Schmieder; Heteronuclear Two- and Three-Dimensional NMR Spectroscopy of 13C in Natural Abundance by Multiplicity Selection and Editing: Application to Peptides; Biopolymers 1991, 31, 621-629.

233.
H. Kessler, P. Schmieder, H. Oschkinat; 3D Heteronuclear NMR Techniques for Carbon-13 in Natural Abundance; J. Am. Chem. Soc. 1990, 112, 8599-8600.

232.
H. Kessler, P. Schmieder, M. Köck, M. Reggelin; Selection of Methyl Resonances in Proton-Detected Heteronuclear Shift Correlation, the HQQC Experiment; J. Magn. Reson. 1991, 91, 375-379.

231.
H. Kessler, S. Mronga, G. Gemmecker; Zero-Quantum Spectroscopy with TOCSY Transfer; J. Magn. Reson. 1990, 87, 633-638.

230.
P. Schmieder, H. Kessler, H. Oschkinat; Schnelle Heterokern-3D-NMR-Spektroskopie; Angew. Chem. 1990, 102, 588-589; Angew. Chem. Int. Ed. Engl. 1990, 29, 546-548.

229.
H. Kessler, U. Anders, M. Schudok; An Unexpected Cis Peptide Bond in the Minor Conformation of a Cyclic Hexapeptide Containing Only Secondary Amide Bonds; J. Am. Chem. Soc. 1990, 112, 5908-5916.

228.
H. Kessler, P. Schmieder, M. Köck, M. Kurz; Improved Resolution in Proton-Detected Heteronuclear Long-Range Correlation; J. Magn. Reson. 1990, 88, 615-618.

227.
H. Kessler, M. Schudok; Short and Efficient Synthesis of Statine and Isostatine-Derivatives; Synthesis 1990, 457-458.

226.
H. Kessler, A. Kling, M. Kottenhahn; Einfache Synthese eines ß(1-3)-verknüpften gal-galactal-Disaccharids und dessen Verwendung in der N-Iodsuccinimid-aktivierten O-Glycopeptid-synthese; Angew. Chem. 1990, 102, 452-454; Angew. Chem. Int. Ed. Engl. 1990, 29, 425-427.

225.
H. Kessler, S. Mronga, M. Will, U. Schmidt; Solution Structure of [Me-L-Leu7] Didemnin B Determined by NMR-Spectroscopy and Refined by MD Calculation; Helv. Chim. Acta 1990, 73, 25-47.

224.
H. Kessler, P. Schmieder, W. Bermel; Complete Assignment of the Noncarbonylic Carbon-13 Resonances of Tendamistat; Biopolymers 1990, 30, 465-475.

223.
H. Kessler, M. Kottenhahn, A. Kling, H. Matter; Synthesis and Conformational Studies of O-Glycopeptides (Proc. 3rd Akabori Conf., German-Japanese Symp. on Peptide Chemistry, Prien/Chiemsee 1989) (Hrsg.: E. Wünsch) Max-Planck-Inst. für Biochemie, Martinsried, 1989, 45-49.

222.
H. Kessler, S. Seip, S. Steuernagel, M. Will, D. Gillessen, T. Kamiyama; The Antibioticum RO 09-0198, a Molecule with Two Different Active Sites; - in: Chemistry of Peptides and Proteins (Vol. 5/6) (Proc. 7th USSR-FRG Symp. on Chemistry of Peptides and Proteins, Dilizhan/USSR, Sept. 23-30, 1989 and 8th FRG-USSR Symp., Aachen, 29.9.-3.10.1991) (Hrsg: D. Brandenburg, V. Ivanov, W. Voelter) Verlag Mainz, Aachen, DWI Reports 1993.

221.
H. Kessler; Peptide Engineering: Design of Biologically Active Peptides under Conformational Control; - in: Trends in Drug Research (Proc. 7th Noordwijkerhout-Camerino Symposium, The Netherlands, 1989) (Hrsg.: V. Claassen) Elsevier Science Publishers, Amsterdam, 1990, 73-84.

220.
H. Kessler, M. Gehrke, J. Lautz, M. Köck, D. Seebach, A. Thaler; Complexation and medium effects on the conformation of cyclosporin A studied by NMR spectroscopy and MD calculations; Biochem. Pharmacol. 1990, 40, 169-173.

219.
H. Kessler, G. Gemmecker, M. Köck, R. Osowski, P. Schmieder; Improvement of Carbon-Detected H,H-TOCSY Experiments by Employing a DEPT Transfer; J. Magn. Reson. 1990, 28, 62-67.


218.
J. Lautz, H. Kessler, W.F. van Gunsteren, H.J.C. Berendsen, R.M. Scheek, R. Kaptein, J. Blaney; Restrained Molecular Dynamics Simulations of Cyclic Peptides, - in: Peptides 1988 (Proc. 20th Europ. Peptide Symp., Tübingen) (hrsg.: G. Jung, E. Bayer) Walter de Gruyter, Berlin, New York, 1989, 438-440.

217.
H. Kessler, P. Schmieder, M. Kurz; Implementation of the DEPT Sequence in Inverse Shift Correlation; the DEPT-HMQC; J. Magn. Reson. 1989, 85, 400-405.

216.
U. Anders, G. Gemmecker, H. Kessler, C. Griesinger; Conformational analysis of amino acid side chains in peptides by quantitative evaluation of cross-peaks in COLOC-spectra; Fresenius Z. Anal. Chem. 1987, 327, 72-73.

215.
H. Kessler, S. Steuernagel; Conformational Determination by NMR Spectroscopy; - in: Peptide Pharmaceuticals - Approaches to the Design of Novel Drugs (Hrsg.: D. Ward) Open University Press, Buckingham, 1991, 18-46.

214.
H. Kessler, U. Anders, G. Gemmecker; Application of Half-Gaussian Shaped Pulses for Selective Excitation; Bruker Report 1989 (No. 1) 31-32.

213.
M. Hofmann, M. Gehrke, W. Bermel, H. Kessler; Proton-Detected C,H-Correlation NMR Techniques for the Complete Assignment of All Proton and Carbon Resonances of a Cyclic Peptide; Magn. Reson. Chem. 1989, 27, 877-886.

212.
H. Kessler, M. Schudok, A. Haupt; Dimerization of Cyclic Hexapeptides: Strong Increase of Biological Activity, - in: Peptides 1988 (Proc. 20th Europ. Pept. Symp., Tübingen) (Hrsg.: G. Jung, E. Bayer) Walter de Gruyter, Berlin, New York, 1989, 664-666.

211.
H. Kessler, U. Anders, G. Gemmecker, S. Steuernagel; Improvement of NMR Experiments by Employing Semiselective Half-Gaussian-Shaped Pulses; J. Magn. Reson. 1989, 85, 1-14.

210.
H. Kessler, M. Will, J. Antel, H. Beck, G.M. Sheldrick; Conformational Analysis of Didemnins. A Multidisciplinary Approach by Means of X-ray, NMR, Molecular Dynamics, and Molecular-Mechanics Techniques; Helv. Chim. Acta 1989, 72, 530-555.

209.
J. Lautz, H. Kessler, W.F. van Gunsteren, H.-P. Weber, R.M. Wenger; On the Dependence of Molecular Conformation on the Type of Solvent Environment: A Molecular Dynamics Study of Cyclosporin A; Biopolymers 1990, 29, 1669-1687.

208.
H. Kessler, R. Kerssebaum, A.G. Klein, R. Obermeier, M. Will; Peptidkonformationen 50. Synthese und Konformationsanalyse von cyclischen Alanin-Analogen des Thymopoietins durch NMR-Spektroskopie und Molecular-Dynamics-Rechnungen im Vakuum und in Lösung; Liebigs Ann. Chem. 1989, 269-294.

207.
H. Kessler, M. Kottenhahn; Synthesis of Linear and Cyclic O-a-Glycopeptides; - in: Peptides 1988 (Proc. of the 20th European Peptide Symposium, Tübingen, 1988) (Hrsg.: G. Jung, E. Bayer) Walter de Gruyter, Berlin, New York, 1989, 331-333.

206.
H. Kessler, J.W. Bats, J. Lautz, A. Müller; Conformation of Antamanide; Liebigs Ann. Chem. 1989, 913-928.

205.
H. Kessler, A. Müller, K.-H. Pook; Assignment of All Proton, Carbon, and Nitrogen NMR Signals of Antamanide in Chloroform Solution; Liebigs Ann. Chem. 1989, 903-912.

204.
H. Kessler, G. Gemmecker, B. Haase, S. Steuernagel; Improvement of Relayed NOESY Type Experiments by Implantation of Spin-Lock Sequences; Magn. Reson. Chem. 1988, 26, 919-926.

203.
H. Kessler, S. Steuernagel, M. Will, G. Jung, R. Kellner, D. Gillessen, T. Kamiyama; The Structure of the Polycyclic Nonadecapeptide Ro 09-0198; Helv. Chim. Acta 1988, 71, 1924-1929.

202.
H. Kessler, J.W. Bats, K. Wagner, M. Will; Conformational Analysis of Cyclic Peptides in Solution; Biopolymers 1989, 28, 385-395.

201.
H. Kessler, A. Haupt, M. Schudok; Structural Optimization of Peptides for cytoprotection of Rat Liver Cells; - in: Peptide Chemistry 1987 (Proc. Jap. Symp. on Peptide Chemistry) (Hrsg: T. Shiba, S. Sakakibara) Protein Research Foundation, Osaka, Japan, 1988, 627-630.

200.
H. Kessler, U. Anders, G. Gemmecker; Determination of Heteronuclear Long-Range Coupling Constants by Soft-H,C-COSY; J. Magn. Reson. 1988, 78, 382-388.

199.
K. Ziegler, M. Frimmer, H. Kessler, A. Haupt; Azidobenzamido-008, a new photosensitive substrate for the "multispecific bile acid transporter" of hepatocytes: evidence for a common transport system for bile acids and cyclosomatostatins in basolateral membranes; Biochem. Biophys. Acta 1988, 945, 263-272.

198.
G. Quinkert, H.G. Schmalz, E. Walzer, S. Grosss, T. Kowalczyk-Przewloka, C. Schierloh, G. Dürner, J.W. Bats, H. Kessler; Totalsynthese des Pseudoguaianolids (+)-Confertin; Liebigs Ann. Chem. 1988, 283-315.

197.
H. Kessler, G. Gemmecker, S. Steuernagel; NOESY-TOCSY, eine vorteilhafte 2D-NMR Technik zur Analyse von Peptidsequenzen; Angew. Chem. 1988, 100, 600-603; Angew. Chem. Int. Ed. Engl. 1988, 27, 564-566.

196.
H. Kessler, M. Will, G.M. Sheldrick, J. Antel; Assignment of Proton and Carbon NMR Signals of Didemnin A in Solution; Magn. Reson. Chem. 1988, 26, 501-506.

195.
H. Kessler, G. Gemmecker, B. Haase; Relayed-NOE Experiments in the Rotating Frame for Sequence Analysis of Peptides; J. Magn. Res. 1988, 77, 401-408.

194.
H. Kessler, A. Haupt, M. Schudok, K. Ziegler, M. Frimmer; Peptide conformations 49. Synthesis and structure-activity-relationships of side chain modified peptides of cyclo(-D-Pro-Phe-Thr-Lys-Trp-Phe-); Int. J. Peptide Protein Res. 1988, 32, 183-193.

193.
H. Kessler, M. Klein, K. Wagner; Peptide conformations 48. Conformation and biological activity of proline containing cyclic retro-analogues of somatostatin; Int. J. Peptide Protein Res. 1988, 31, 481-498.

192.
H. Kessler, C. Griesinger, J. Lautz, A. Müller, W.F. van Gunsteren, H.J.C. Berendsen; Conformational Dynamics Detected by Nuclear Magnetic Resonance NOE-Values and J Coupling Constants; J. Am. Chem. Soc. 1988, 110, 3393-3396.

191.
K.H. Usadel, H. Kessler, G. Rohr, K. Kusterer, K.D. Palitzsch, U. Schwedes; Cytoprotection by Somatostatins; - in: Somatostatin, Basic and Clinical Status (Hrsg.: S. Reichlin) Plenum Press, New York, London, 1987, 193-200.

190.
J. Lautz, H. Kessler, J.M. Blaney, R.M. Scheek, W.F. van Gunsteren; Calculating three-dimensional molecular structure from atom-atom distance information: cyclosporin A; Int. J. Pept. Prot. Res. 1989, 33, 281-288.

189.
H. Kessler, A. Haupt, M. Will; Design of Conformationally Restricted Cyclopeptides for the Inhibition of Cholate Uptake of Hepatocytes; - in: Computer Aided Drug Design (Hrsg.: T.J. Perun, C.L. Probst) Marcel Dekker, New York, 1989, 461-484.

188.
H. Kessler, G. Gemmecker, A. Haupt, M. Klein, K. Wagner, M. Will; Peptide Conformations 47. Alanine Containing Analogues of Cyclo-(D-Pro-Phe-Thr-Lys(Z)-Trp-Phe-) - Conformationally Controlled Structure-Activity-Relationships; Tetrahedron 1988, 44, 745-759.

187.
H. Kessler, G. Gemmecker, A. Haupt, J. Lautz, M. Will; Cytoprotective Peptides - Conformational Analysis of a Superpotent Cyclic Hexapeptide Using NMR Spectroscopy and MD Calculations; - in: NMR Spectroscopy and Drug Research (Alfred Benzon Symposium 26) (Hrsg.: J.W. Jaroszewki, K. Schaumburg, H. Kofod) Munksgaard, Copenhagen, 1988, 138-152.

186.
G. Quinkert, U. Billhardt, H. Jacob, H. Fischer, J. Glenneberg, P. Nagler, V. Autze, N. Heim, M. Wacker, T. Schwalbe, Y. Kurth, J.W. Bats, G. Dürner, G. Zimmermann, H. Kessler; Photolactonisierung: ein neuer synthetischer Zugang zu Makroliden; Helv. Chim. Acta 1987, 70, 771-861.

185.
H. Kessler, K. Wagner, M. Will; Conformational analysis of a cyclic hexapeptide by rotating frame NOE (ROE) evaluation and molecular dynamics (MD) calculations; - in: Peptides 1987 (Proc. 10th Am. Pept. Symp., St. Louis) (Hrsg.: G.R. Marshall) ESCOM Science Publ., Leiden, The Netherlands, 1988, 35-36.

184.
H. Kessler, M. Gehrke, C. Griesinger; Zweidimensionale NMR-Spektroskopie, Grundlagen und Übersicht über die Experimente; Angew. Chem. 1988, 100, 507-554; Angew. Chem. Int. Ed. Engl. 1988, 27, 490-536.

183.
H. Kessler, M. Kottenhahn, A. Kling, C. Kolar; Synthese von O-(a-Glyco)peptiden mit dem N-Iodsuccinimid-Verfahren; Angew. Chem. 1987, 99, 919-921; Angew. Chem. Int. Ed. Engl. 1987, 26, 888-890.

182.
H. Kessler, J.W. Bats, C. Griesinger, S. Koll, M. Will, K.W. Wagner; Peptide Conformations 46. Conformational Analysis of a Superpotent Cytoprotective Cyclic Somatostatin Analogue; J. Am. Chem. Soc. 1988, 110, 1033-1049.

181.
H. Kessler, S. Steuernagel, D. Gillessen, T. Kamiyama; Complete Sequence Determination and Localisation of One Imino and Three Sulfide Bridges of the Nonadecapeptide Ro 09-0198 by Homonuclear 2D-NMR Spectroscopy. The DQF-RELAYED-NOESY-Experiment; Helv. Chim. Acta 1987, 70, 726-741.

180.
J. Lautz, H. Kessler, R. Boelens, R. Kaptein, W.F. van Gunsteren; Peptide conformations 45. Conformational analysis of a cyclic thymopoietin-analogue by 1H n.m.r. spectroscopy and restrained molecular dynamics simulations; Int. J. Peptide Protein Res. 1987, 30, 404-414.

179.
J. Lautz, H. Kessler, R. Kaptein, W.F. van Gunsteren; Molecular dynamics simulation of cyclosporin A: The crystal structure and dynamic modelling of a structure in apolar solution based on NMR data; J. Comp.-Aided Mol. Design 1987, 1, 219-241.

178.
H. Kessler, K. Wagner, M. Will; Peptide Conformations 44. Analysis of Peptides Conformation by NMR Spectroscopy; - in: Trends in Medicinal Chemistry (Proc. 9th Int. Symp. Med. Chem., Berlin) (Hrsg.: F. Mutschler, E. Winterfeld) VCH, Weinheim, 1987, 143-157.

177.
H. Kessler, A. Haupt, M. Klein, K. Wagner; Peptide Conformations 43. Common Structural Features for Cytoprotection Activity of Cyclic Retro Analogues of Somatostatin; - in: Peptides 1986 (Proc. 19th European Pept. Symp.) (Hrsg.: D. Theodoropoulus) Walter de Gruyter, Berlin, New York, 1987, 327-330.

176.
H. Kessler, A. Haupt, M. Frimmer, K. Ziegler; Synthesis of a cyclic retro analogue of somatostatin suitable for photoaffinity labelling; Int. J. Peptide Protein Res. 1987, 29, 621-628.

175.
H. Kessler, C. Griesinger, K. Wagner; Peptide Conformations 42. Conformation of Side Chains in Peptides Using Heteronuclear Coupling Constants Obtained by Two-Dimensional NMR Spectroscopy; J. Am. Chem. Soc. 1987, 109, 6927-6933.

174.
H. Kessler, C. Griesinger, R. Kerssebaum, K. Wagner, R.R. Ernst; Separation of Cross-Relaxation and J Cross-Peaks in 2D Rotating-Frame NMR Spectroscopy; J. Am. Chem. Soc. 1987, 109, 607-609.

173.
W. Bermel, C. Griesinger, H. Kessler, K. Wagner; Assignment of Carbonyl Groups and Sequence Analysis in Peptides by Inverse Correlation Using Long-Range Couplings; Magn. Reson. Chem. 1987, 25, 325-326.

172.
H. Kessler, C. Griesinger, G. Zimmermann; Comparison of Four Pulse Sequences for the Routine Application of Proton-Carbon Shift Correlation; Magn. Reson. Chem. 1987, 25, 579-583.

171.
H. Kessler, M. Klein, A. Müller, K. Wagner, J.W. Bats, K. Ziegler, M. Frimmer; Konformative Voraussetzungen für die biologische Aktivität von cytoptotectiv wirksamen Cyclopeptiden; Angew. Chem. 1986, 98, 1030-1032; Angew. Chem. Int. Ed. Engl. 1986, 25, 997-999.

170.
G.S. Rao, H. Lemoch, H. Kessler, I. Damm, V. Eiermann, S. Koll, J. Zarbock, K.H. Usadel; Prevention of Phalloidin-induced Lesions on Isolated Rat Hepatocytes by Novel Synthetic Analogues of Somatostatin; Klin. Wochenschr. 1986, 64 (Suppl. VII) 79-86.

169.
K.H. Usadel, H. Kessler, G. Rohr, K. Kusterer, K.D. Palitzsch, U. Schwedes; Cytoprotective Properties of Somatostatins; Klin. Wochenschr. 1986, 64 (Suppl. VII) 59-63.

168.
H. Kessler, M. Gehrke, A. Haupt, M. Klein, A. Müller, K. Wagner; Common Structural Features for Cytoprotection Activities of Somatostatin, Antamanide and Related Peptides, Klin. Wochenschr. 1986, 64 (Suppl. VII) 74-78.

167.
H. Kessler; Designing Activity and Receptor Selectivity in Cyclic Peptide Hormone Analogs; - in: Design and Synthesis of Organic Molecules Based on Molecular Recognition (Hrsg.: G. van Binst) Springer Verlag, Berlin 1986, 301-304.

166.
H. Kessler, H. Oschkinat, C. Griesinger, W. Bermel; Transformation of Homonuclear Two-Dimensional NMR Techniques into One-Dimensional Techniques Using Gaussian Pulses; J. Magn. Reson. 1986, 70, 106-133.

165.
H. Kessler, A. Müller; Peptidkonformationen 41. Eine ungewöhnliche Konformation des cyclischen Peptapeptids cyclo-(Pro-Pro-Phe-Phe-Gly-) in DMSO; Liebigs Ann. Chem. 1986, 1687-1704.

164.
H. Kessler, W. Bermel, C. Griesinger, C. Kolar; NMR-spektroskopische Konstitutionsaufklärung von Glycopeptiden mit der COLOC-Technik; Angew. Chem. 1986, 98, 352-353; Angew. Chem. Int. Ed. Engl. 1986, 25, 342-344.

163.
H. Kessler, B. Kutscher; Peptidkonformationen 40. Cyclische Hexapeptidanaloge des Thymopoietins. Synthese und Konformationsstudien; Liebigs Ann. Chem. 1986, 914-931.

162.
H. Kessler, B. Kutscher, A. Klein; Peptidkonformationen 39. NMR-Studien zur Konformation von Cyclopentapeptidanalogen des Thymopoietins; Liebigs Ann. Chem. 1986, 893-913.

161.
H. Kessler, B. Kutscher; Synthese von cyclischen Pentapeptidanalogen des Thymopoietins. Cyclisierungen mit Carbodiimid und 4-(Dimethylamino)pyridin; Liebigs Ann. Chem. 1986, 869-892.

160.
G. Quinkert, N. Heim, J. W. Bats, H. Oschkinat, H. Kessler; Die Struktur des Flechten-Macrolids (+)-Aspicilin; Angew. Chem. 1985, 97, 985-986; Angew. Chem. Int. Ed. Engl. 1985, 24, 987-988.

159.
H. Kessler, G. Becker, H. Kogler, J. Friese, R. Kerssebaum; 2-(2'-Pyridyl)-ethyl-ester (Pet-ester) derivatives of polyfunctional amino acids; Int. J. Pept. Prot. Res. 1986, 28, 342-346.

158.
H. Kessler, W. Bermel, C. Griesinger, P. Hertl, E. Streich, A. Rieker; Assignments of the Carbon Resonances in tert-Butylated 2-Naphthols by the Two-Dimensional C-Relayed H,C-COSY Technique; J. Org. Chem. 1986, 51, 596-601.

157.
H. Kessler, B. Kutscher, R. Kerssebaum, A. Klein, J. Lautz, R. Obermeier, H. Müllner, W.F. van Gunsteren, R. Boelens, R. Kaptein; Design, Synthesis, and Conformation of Superactive Thymopoietin-Analogues - in: Peptides - Structure and Fucntion (Proc. 9th Amer. Pept. Symp.) (Hrsg.: C.M. Deber, V.J. Hruby, K.D. Kopple) Pierce Chem. Comp., Rockford, Ill., USA, 1985, 83-92.

156.
C. Zechel, H. Kessler, R. Geiger; Peptide Conformations 37. Synthesis and Conformational Studies of Enkephalinlike Cyclic Peptides and Depsipeptides - in: Peptides, Structure and Function (Proc. 9th Amer. Pept. Symp.) (Hrsg.: C.M. Deber, V.J. Hruby, K.D. Kopple) Pierce Chem. Comp. Rockford, Ill. USA, 1985, 507-510.

155.
K. Eckard, H. Schwarz, G. Becker, H. Kessler; Monitoring and Optimization of Deprotection Reactions of Peptides by Direct Sampling with Fast Atom Bombardment Mass Spectrometry; J. Org. Chem. 1986, 51, 483-486.

154.
H. Kessler, H. Oschkinat, H. R. Loosli; Two-Dimensional NMR Spectroscopy on the Immunosuppressive Peptide, Cyclosporin A - in: Methods in Stereochemical Analysis (Hrsg.: R. M. Carlson, W. R. Croasmun) Verlag Chemie International, Deerfield Beach, USA, 1987 (Vol. 9) 259-299.

153.
H. Kessler, M. Kühn, T. Löschner; Synthese von Virginiamycin S1 und Virginiamycin S4; Liebigs Ann. Chem. 1986, 21-31.

152.
H. Kessler, M. Kühn, T. Löschner; Synthese des Benzylethers von Virginiamycin S1; Liebigs Ann. Chem. 1986, 1-20.

151.
H. Kessler, H. Oschkinat; Spektrenvereinfachung zur Ermittlung von Kopplungskonstanten aus homonuclear-korrelierten 2D-NMR-Spektren; Angew. Chem. 1985, 97, 689-690; Angew. Chem. Int. Ed. Engl. 1985, 24, 690-692.

150.
G. Hägele, W. Kückelhaus, J. Seega, G. Tossing, H. Kessler, R. Schuck; Methylsubstituierte Phosphorverbindungen, II. L-Men (R)P(X)Cl (R = Cl, L-Men, D-Men; X = :,S). Charakterisierung singulärer, diastereotoper und enantiotoper Methylgruppen durch 1H-, 13C- und 31P-NMR-Techniken; Z. Naturforsch. 1985, 40b, 1053-1063.

149.
H. Kessler, A. Müller, H. Oschkinat; Differences and Sums of Traces within COSY-Spectra (DISCO) for the Extraction of Coupling Constants: 'Decoupling' After the Measurement; Magn. Reson. Chem. 1985, 23, 844-852.

148.
H. Kessler, W. Bermel, A. Müller, K.-H. Pook; Modern NMR Spectroscopy of Peptides - in: The Peptides (Hrsg.: S. Udenfried, J. Meienhofer, V. J. Hruby) Academic Press, Orlando, 1985 (Vol. 7) 437-473.

147.
K. Ziegler, M. Frimmer, H. Kessler, I. Damm, V. Eiermann, S. Koll, J. Zarbock; Modified somatostatins as inhibitors of a multispecific transport system for bile acids and phallotoxins in isolated heptatocytes; Biochim. Biophys. Acta 1985, 845, 86-93.

146.
H. Kessler, W. Bermel, C. Griesinger; Determination of Carbon-Carbon Connectivities, Assignment of Quaternary Carbons, and Extraction of Carbon-Carbon Coupling Constants by Carbon-Related Hydrogen-Carbon Spectroscopy; J. Magn. Reson. 1985, 62, 573-579.

145.
H. Kessler, M. Bernd; Peptidkonformationen 36. Konformationsuntersuchungen an vier cyclischen Heptapeptiden durch NMR-Spektroskopie; Liebigs Ann. Chem. 1985, 1145-1167.

144.
H. Kessler, B. Kutscher; Synthesis and NMR Investigation of Cyclic Pentapeptide Analogues of Thymopentin; Tetrahedron Lett. 1985, 26, 177-180.

143.
H. Kessler, W. Bermel, C. Griesinger; Recognition of NMR Proton Spin Systems of Cyclosporin A via Heteronuclear Proton-Carbon Long-Range Couplings; J. Am. Chem. Soc. 1985, 107, 1083-1084.

142.
Kessler, H.; Loosli, H. R.; Oschkinat, H.; Investigation of Peptides by Two-Dimensional NMR Spectroscopy - The Conformation of Cyclosporin A in Solution, in: "Peptides 1984" (Proc. 18th Europ. Pept. Symp., Schweden) - Ragnarsson, U. (Ed.) Almqvist u. Wiksell, Int., Uppsala 1984, 65-79.

141.
Kessler, H.; Becker, G.; Kogler, H.; Wolff, M.; 2-(2-Pyridyl-)Ethyl Esters. A New Carboxyl Protecting Group in Peptide Synthesis, Tetrahedron Lett. 25, 3971-3974 (1984).

140.
Kessler, H.; Bermel, W.; Peptide Conformations 34. Conformational Analysis of Peptides by Two-Dimensional NMR Spectroscopy, in: "Methods of Stereochemical Analysis" (Vol. 6) - Takeuchi, A.; Marchand, P. (Eds.) VCH Publishers, Inc. 1986, 179-205.

139.
Kessler, H.; Hölzemann, G.; Zechel, C.; Peptide conformations 33. Conformational analysis of cyclic enkephalin analogs of the type Tyr-cyclo-(Nw-Xxx-Gly-Phe-Leu-), Int. J. Peptide Protein Res. 25, 267-279 (1985).

138.
H. Kessler, C. Griesinger, J. Lautz; Bestimmung von Konnektivitäten über kleine Protonen-Kohlenstoff-Kopplungen mit einer neuen zweidimensionalen NMR-Technik, Angew. Chem. 1984, 96, 434-435); Angew. Chem. Int. Ed. Engl. 1984, 23, 444-459.

137.
H. Kessler, C. Griesinger, J. Zarbock, H.R. Loosli; Peptide Conformations 32. Assignment of Carbonyl Carbons and Sequence Analysis in Peptides by Heteronuclear Shift Correlation via Small Coupling Constants with Broadband Decoupling in t1 (COLOC), J. Magn. Reson. 1984, 57, 331-336.

136.
H.R. Loosli, H. Kessler, H. Oschkinat, H.P. Weber, T.J. Petcher, A. Widmer; Peptide Conformations 31. The Conformation of Cyclosporin A in in the Crystal and in Solution, Helv. Chim. Acta 1985, 68, 682-704.

135.
H. Kessler, H.R. Loosli, H. Oschkinat; Peptide Conformations, XXX. Assignment of the 1H-, 13C-, and 15N-NMR Spectra of Cyclosporin A in CDCl3 and C6D6 by a Combination of Homo- and Heteronuclear Two-Dimensional Techniques, Helv. Chim. Acta 1985, 68, 661-681.

134.
M. Bickel, H. Kessler, W. König, V. Teetz, W. Stoll; Long-term inhibition of gastric acid secretion by somatostatin and analogues in rats, Acta Endocrinologica (Suppl. 253) 1983, 102, 106-107.

133.
H. Kessler, H. Oschkinat, O.W. Sþrensen, H. Kogler, R.R. Ernst; Multiple-Quantum-Filtered Homonuclear J,d Spectra, J. Magn. Reson. 1983, 55, 329-333.

132.
H. Kessler, G. Hölzemann, R. Geiger; Peptide Conformations, XXIX. Conformational Studies of Some Cyclic Enkephalin Analogues by Two-dimensional NMR-Spectroscopy, in Peptides: Structure, Function, Activity (Proc. 8th Am. Pept. Symp.) (Hrsg.: V. Hruby, D.H. Rich) Pierce Chemical Comp., Rockford, Ill., USA 1983, 295-298.

131.
H. Kessler, H. Oschkinat, G. Zimmermann, H. Möhrle, M. Bieghold, W. Arz, H. Förster; Anwendung der hochaufgelösten Festkörper-NMR-Spektroskopie zur Bestimmung der Ring-Ketten-Tautomerie, Chem. Ber. 1984, 117, 702-709.

130.
H. Kessler, B. Kutscher, G. Mager, E. Grell; Synthese des Streptogramin-B-analogen Cyclodepsipeptides cyclo[-(Boc)Ser-D-Abu-Pro-(Me)Phe-Pip-Phg-O], Liebigs Ann. Chem. 1983, 1541-1550.

129.
H. Kessler, M. Bernd, H. Kogler, J. Zarbock, O.W. Sþrensen, G. Bodenhausen, R.R. Ernst; Peptide Conformations, XXVIII. Relayed Heteronuclear Correlation Spectroscopy and Conformational Analysis of Cyclic Hexapeptides Containing the Active Sequence of Somatostatin, J. Am. Chem. Soc. 1983, 105, 6944-6952.

128.
H. Kessler, W. Bermel, G. Krack, J.W. Bats, H. Fuess, W.E. Hull; Peptidkonformationen, XXVII. cyclo-[L-Pro-(Bzl)Gly-D-Pro]. Synthese und Konformation im Kristall und in Lösung, Chem. Ber. 1983, 116, 3164-3181.

127.
H. Kessler, H. Kogler; Peptidkonformationen, XXVI. Ein- und zweidimensionale 1H-NMR-Untersuchung zur Konformation der beiden cyclischen Pentapeptide cyclo-[Pro-Phe-Gly-Ser-Gly] und cyclo-[Pro-Ser-Gly-Phe-Gly], Liebigs Ann. Chem. 1983, 316-329.

126.
H. Kessler, R. Siegmeier; 9-Fluorenylmethyl Esters as Carboxyl Protecting Group, Tetrahedron Lett. 1983, 24, 281-282.

125.
H. Kessler, R. Schuck; Peptide Conformations, XXV. Application of Homonuclear and Heteronuclear Two-Dimensional NMR-Spectroscopy to Cyclolinopeptide A, in Peptides 1982 (Hrsg.: K. Blaha, P. Malon) Walter de Gruyter, Berlin 1983, 797-800.

124.
H. Kessler, V. Eiermann; Peptide Conformations, XXIV. Homo- and Heteronuclear 2D NMR Spectroscopy of Cyclic Pentapeptides Containing the Active Sequence of Somatostatin, Tetrahedron Lett. 1982, 23, 4689-4692.

123.
H. Kessler, M. Bernd, I. Damm; Peptide Conformations, XXIII. NMR Investigations of Cyclic Hexapeptides Containing the Active Sequence of Somatostatin, Tetrahedron Lett. 1982, 23, 4685-4688.

122.
H. Kessler, R. Schuck, R. Siegmeier, J.W. Bats, H. Fuess, H. Förster; Peptidkonformationen, XXII. Die Konformation von cyclo-[Pro2-(NB)GLy] im Kristall und in Lösung durch Röntgen-strukturanalyse und ein- und zweidimensionaler NMR-Spektroskopie, Liebigs Ann. Chem. 1983, 231-247.

121.
H. Kessler, R. Schuck; Peptide Conformations, XXI. Homo- and Heteronuclear Two-Dimensional NMR Spectroscopy of Cyclic Peptides, in Chemistry of Peptides and Proteins (Hrsg.: W. Voelter, E. Bayer, Y.A. Ovchinnikov, E. Wünsch) Walter de Gruyter, Berlin 1984 (Vol. 2) 233-238.

120.
F.A.A.M. de Leeuw, C. Altona, H. Kessler, W. Bermel, A. Friedrich, G. Krack, W.E. Hull; Peptide Conformations, XX. Conformational Analysis of Proline Rings from Proton Spin-Spin Coupling Constants and Force-Field Calculations: Application to Three Cyclic Tripeptides, J. Am. Chem. Soc. 1983, 105, 2237-2246.

119.
H. Kessler; Peptidkonformationen, XIX. Konformation und biologische Wirkung von cyclischen Peptiden, Angew. Chem. 1982, 94, 509-520; Angew. Chem. Int. Ed. Engl. 1982, 21, 512-523.

118.
H. Kessler, R. Schuck, R. Siegmeier; Peptide Conformation, XVIII. Analysis of the Conformational Equilibrium of cyclo[Pro-NBGLy2] by means of Two-dimensional NMR-Spectroscopy, J. Am. Chem. Soc. 1982, 104, 4486-4487.

117.
H. Kessler, W. Bermel, A. Friedrich, G. Krack, W.E. Hull; Peptide Conformation, XVII. cyclo-(L-Pro-L-Pro-D-Pro). Conformational Analysis by 270- and 500-MHz One- and Two-Dimensional 1H NMR-Spectroscopy, J. Am. Chem. Soc. 1982, 104, 6297-6304.

116.
H. Kessler, D. Ziessow; Zweidimensionale NMR-Spektroskopie, Nachr. Chem. Tech. Lab. 1982, 30, 488-497.

115.
H. Kessler, W. Bermel, H. Förster; Peptidkonformationen, XVI. Festkörper-13C-NMR-Spektren von Cyclotriprolinen, Angew. Chem. 1982, 94, 703; Angew. Chem. Int. Ed. Engl. 1982, 21, 689.

114.
H. Kessler, W. Hehlein, R. Schuck; Peptide Conformations, XV. One and Two-Dimensional 1H-, 13C-, and 15N- NMR Studies of cyclo(Pro-Phe-Gly-Phe-Gly)n (n = 1, 2): Selective Complexation of Lithium Ions (n = 1) and Potassium Ions (n = 2), J. Am. Chem. Soc. 1982, 104, 4534-4540.

113.
H. Kessler, G. Zimmermann, H. Förster, J. Engel. G. Oepen, W.S. Sheldrick; Ist die Konformation eines Moleküls im Kristall und in Lösung gleich? NMR-Befunde an Festkörper und Lösung im Vergleich zur Röntgen-Strukturbestimmung, Angew. Chem. 1981, 93, 1085-1086; Angew. Chem. Int. Ed. Engl. 1981, 20, 1053-1055.

112.
H. Kessler, A. Friedrich, G. Krack, W.E. Hull; Peptide Conformations, XIV. NMR Analysis and Conformation of Cyclotriprolines, in Peptides: Synthesis, Structure, Function (Hrsg.: D.H. Rich, E. Gross) Pierce Chemical Comp., Rockford, Ill., USA, 1981, 335-338.

111.
H. Kessler, G. Hölzemann; Peptidkonformationen, XIII. cyclo-Enkephaline - Synthese und Konformationsstudien, Liebigs Ann. Chem. 1981, 2028-2044.

110.
H. Kessler, M. Feigel; Direct Observation of Recombination Barriers of Ion Pairs by Dynamic NMR Spectroscopy, Acc. Chem. Res. 1982, 15, 2-8.

109.
H. Kessler, G. Krack, G. Zimmermann; Double-INDOR-Difference Spectroscopy (DID). A Simple Method to Aid the Analysis of Overlapping Spin Systems, J. Magn. Reson. 1981, 44, 208-211.

108.
H. Kessler, A. Friedrich, W.E. Hull; Peptide Conformation, XII. Conformation of Cyclo-(L-Pro3) in Solution, J. Org. Chem. 1981, 46, 3892-3895.

107.
H. Kessler, G. Hölzemann; Peptidkonformation, XI. cyclo-Leu(5)-Enkephalin, Angew. Chem. 1981, 93, 90-91; Angew. Chem. Int. Ed. Engl. 1981, 20, 124-125.

106.
G. Binsch, H. Kessler; Die kinetische und mechanistische Auswertung von NMR-Spektren, Angew. Chem. 1980, 92, 445-463; Angew. Chem. Int. Ed. Engl. 1980, 19, 411-428.

105.
P. Kondor, H. Kessler; Peptide Conformations, X. Conformation of Cyclic 5-Peptides, in Peptides: Structure and Function (Proc. 9th Am. Pept. Symp.) (Hrsg.: E. Gross, J. Meienhofer) Pierce Chemical Comp., Rockford, Ill., USA, 1979, 181-184.

104.
H. Kessler, P. Krämer, G. Krack; Peptide Conformations, IX. Conformational Studies on Cyclotripeptides Containing N-Benzyl-Glycine, Isr. J. Chem. 1980, 20, 188-195.

103.
H. Kessler; Peptide Conformations, VIII. Conformational Mobility of the Backbone of Cyclic Tripeptides, in Stereodynamics of Molecular Systems (Hrsg.: R.H. Sarma) Pergamon Press, Oxford, New York, Frankfurt, Paris, 1979, 187-196.

102.
J.W. Bats, H. Fuess, H. Kessler, R. Schuck; Zur Konformation geschützter Aminosäuren, VI. tert-Butoxycarbonyl-L-a-phenylalanin. Kristallstruktur und Konformationsumwandlungen in Lösung., Chem. Ber. 1980, 113, 520-530.


101.
J.W. Bats, A. Friedrich, H. Fuess, H. Kessler, W. Mästle, M. Rothe; Peptidkonformationen, VII. Die Bootkonformation von cyclo-[L-Pro2-D-Pro], Angew. Chem. 1979, 91, 573-574; Angew. Chem. Int. Ed. Engl. 1979, 18, 538-539.

100.
H. Kessler, W. Ott, J. Lindner, H.G. von Schnering, E.M. Peters, K. Peters; Die Struktur des 2,6-Diphenyl-homotropilidens, Chem. Ber. 1980, 113, 90-103.

99.
M. Feigel, H. Kessler; NMR-spektroskopische Untersuchungen zur Kinetik und Thermodynamik reversibler Dissoziationsreaktionen, VII. Direkte Beobachtung der Ionisation und Ionenrekombination von Tritylchlorid in SO2, Chem. Ber. 1979, 112, 3715-3722.

98.
H. Kessler, P. Kondor; Peptidkonformationen, VI. Festlegung von intramolekularen Wasserstoffbrücken in cyclo(-Phe-Gly-Xxx-Val-Ala-) durch 1H-NMR-Spektroskopie, Chem. Ber. 1979. 112, 3538-3551.

97.
R.W. Hoffmann, N. Hauel, F. Frickel, H. Kessler, M. Kempf; 5-Methoxysemibullvalen, Chem. Ber. 1979, 112, 2894-2902.

96.
M. Feigel, H. Kessler, D. Leibfritz, A. Walter; NMR Spectroscopic Studies on Kinetics and Thermodynamics of Reversible Dissoziation Reactions, VI. Ionization of Tropylium Azide in Liquid Sulfur Dioxide and Selective Migration of the Azide Ligand in Less Polar, J. Am. Chem. Soc. 1979, 101, 1943-1950.

95.
H. Kessler, G. Krack, P. Krämer; Peptide Conformations, V. Conformational Equilibrium in the Backbone of Cyclic Tripeptides, in Peptides 1978 (Proc. 15th European Pept. Symp., Gdansk, Polen) (Hrsg.: I.Z. Siemion, G. Kupryszewski) Wroclaw University Press, Poland, 1979, 301-304.

94.
H.O. Kalinowski, H. Kessler; p-Donoreigenschaften von Sauerstoff und Schwefel - DNMR Studien an aromatischen Uronium- und Thiouroniumsalzen zur Frage der planaren Inversion am Sauerstoff und Schwefel, Chem. Ber. 1979, 112, 1153-1167.

93.
R. Bicker, H. Kessler, A. Steigel, G. Zimmermann; 13C-NMR-Spektroskopie von Norbornanderivaten, II. Einfluß homokonjugativer Wechselwirkungen auf die Carbonylverschiebung in Norbornan-systemen, Chem. Ber. 1978, 111, 3215-3221.

92.
R. Bicker, H. Kessler, G. Zimmermann; 13C-NMR-Spektroskopie von Norbornanderivaten, I. Gerüstabhängige Verschiebungseffekte und ihre Nichtadditivität als Indikator für Intramolekulare Wechselwirkungen, Chem. Ber. 1978, 111, 3200-3214.

91.
M. Feigel, H. Kessler, A. Walter; NMR-Spektroskopische Untersuchungen zur Kinetik und Thermodynamik reversibler Dissoziationskonstanten, V. Das Gleichgewicht zwischen Kontaktionenpaaren des Tropyliumisothiocyanats und kovalenten 7-Isothiocyanatocycloheptatrien - 1H- und 13C-NMR-Messungen, Chem. Ber. 1978, 111, 2947-2959.

90.
H. Kessler, G. Zimmermann, H. Fietze, H. Möhrle; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXX. Simultane Beobachtung dreier reversibler Austauschprozesse im Diphenylborinsäure-diethanolaminester - eine 1H- und 13C-DNMR-spektroskopische Untersuchung, Chem. Ber. 1978, 111, 2605-2614.

89.
H. Kessler, Y.A. Bara, A. Friedrich, W. Hehlein, P. Kondor, M. Molter; Peptide Conformations, IV. Conformational Studies of Cyclic Pentapeptides by NMR-Spectroscopy, in Peptides 1977 (Proc. 5th Amer. Peptide Symp., San Diego, Calif.) (Hrsg.: M. Goodman, J. Meienhofer) John Wiley & Sons, New York, 1977, 343-345.

88.
H. Kessler, P. Kondor, G. Krack, P. Krämer; Peptide Conformations, III. Conformational Equilibrium in the Backbone of Cyclic Tripeptides, J. Am. Chem. Soc. 1978, 100, 2548-2550.

87.
M. Feigel, H. Kessler; NMR-Spektroskopische Untersuchungen zur Kinetik und Thermodynamik reversibler Dissoziationsreaktionen, IV. Tris(4-methoxyphenyl)methyl-isothiocyanat - Direkte Beobachtung und Linienformanalyse der Ionisierung und der Ionenpaar-Rekombination, Chem. Ber. 1978, 111, 1659-1669.

86.
Y.A. Bara, A. Friedrich, H. Kessler, M. Molter; Peptidkonformationen, II. 1H-NMR-Untersuchungen zur Konformation von cyclo(-Phe3-Gly2-), Chem. Ber. 1978, 111, 1045-1057.

85.
Y.A. Bara, A. Friedrich, W. Hehlein, H. Kessler, P. Kondor, M. Molter, H.-J. Veith; Synthese der cyclischen Pentapeptide aus L-Phenylalanin und Glycin, Chem. Ber. 1978, 111, 1029-1044.

84.
M. Feigel, H. Kessler; Die Barriere der Ionisierung von Tritylchlorid in Schwefeldioxid, Angew. Chem. 1977, 89, 266-267; Angew. Chem. Int. Ed. Engl. 1977, 16, 256-257.

83.
H. Kessler, G. Zimmermann; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXIX. 13C-DNMR-Studie zur molekularen Beweglichkeit von a-Tripiperidein, Chem. Ber. 1977, 110, 2306-2315.

82.
H. Kessler, H. Möhrle, G. Zimmermann; Determination of the Configuration and Conformation of a-, ß-, and Isotripiperideine by Carbon-13 NMR-Spectroscopy, J. Org. Chem. 1977, 42, 66-72.

81.
D. Demel, H. Kessler; Peptide Conformations, I. Conformation of cyclo[Pro-Phe-Gly-Phe-Gly], Tetrahedron Lett. 1976, 2801-2804.

80.
H. Kessler, W. Ott; 2,6-Substituted Homotropilidenes. Influence of Substituents on Valence Topomerization, J. Am. Chem. Soc. 1976, 98, 5014-5016.

79.
H. Kessler, M. Molter; Conformation of Protected Amino Acids, V. Application of Lanthanide Shift Reagents for Conformational Studies of tert-Butoxycarbonyl a-Amino Acid Esters: Equilibrium Changes and Kinetics of the Isomerization, J. Am. Chem. Soc. 1976, 98, 5969-5973.

78.
M. Feigel, H. Kessler; NMR-spektroskopische Untersuchungen zur Kinetik und Thermodynamik reversibler Dissoziationsreaktionen, II. Chlortropyliumchlorid-chlorsubstituierte 7-Chlorcycloheptatriene: Gleichgewichte und Halogenwanderung, Tetrahedron 1976, 32, 1575-1579.

77.
R. Bicker, H. Kessler, W. Ott; Substituenteneinfluß auf sigmatrope Reaktionen, II. 13C-DNMR-Untersuchungen zur Kinetik der Valenzisomerisierung von 3,4-Homotropiliden und seines 3-Methylderivates, Chem. Ber. 1975, 108, 3151-3158.

76.
R. Bicker, M. Kempf, H. Kessler; Eine verbesserte Synthese von Norbornadienon-dimethylacetal, Synthesis 1975, 427-428.

75.
M. Branik, H. Kessler; Zur Konformation geschützter Aminosäuren, IV. NMR- und IR-Untersuchungen von Boc-w-Aminosäuren, Chem. Ber. 1975, 108, 2722-2727.

74.
R. Bicker, H. Kessler, A. Steigel, W.D. Stohrer; Substituenteneinfluß auf sigmatrope Reaktionen, I. 3-Methylhomotropiliden. Synthese und Lage des Gleichgewichtes, Chem. Ber. 1975, 108, 2708-2721.

73.
M. Branik, H. Kessler; Zur Konformation geschützter Aminosäuren, III. NMR- und IR-Untersuchungen von Boc-L-a-Aminosäuren, Chem. Ber. 1975, 108, 2176-2188.

72.
H.O. Kalinowski, H. Kessler; Mesomere Kationen, IV. 13C-NMR-Spektren von Uronium-, Thiouronium- und Guanidiniumsalzen, sowie einigen Guanidinen, Org. Magn. Reson. 1975, 7, 128-136.

71.
R. Bicker, H. Kessler, A. Steigel; Ungewöhnlicher Verlauf einer Acetalhydrolyse bei einer Homotropiliden-Synthese, Chem. Ber. 1974, 107, 3053-3069.

70.
H. Kessler, M. Molter; Anwendung der Eu(fod)3-induzierten Verschiebung zur Festlegung des Komplexierungsortes und zur Signalzuordnung in 13C-NMR-Spektren geschützter Dipeptide, Angew. Chem. 1974, 86, 553-554; Angew. Chem. Int. Ed. Engl. 1974, 13, 538-539.

69.
H. Kessler, M. Molter; Kontakt-Anteil bei der lanthanoid-induzierten Verschiebung von 13C=O-NMR-Signalen, Angew. Chem. 1974, 86, 552-553; Angew. Chem. Int. Ed. Engl. 1974, 13, 537-538.

68.
H. Moehrle, J. Tenczer, H. Kessler, G. Zimmermann; Die Struktur von Philocarpin-Salzen, Arch. Pharm. 1975, 308, 11-22.

67.
H. Kessler, W. Ott; Synthese von substituierten Homotropilidenen durch Homo-1,4-Eliminierung, Tetrahedron Lett. 1974, 1383-1386.

66.
H. Kessler; Thermal Isomerization about Double Bonds - Rotation and Inversion, Tetrahedron 1974, 30, 1861-1870.

65.
H.O. Kalinowski, H. Kessler; Mesomere Kationen, III. 13C-Fourier Transform-NMR-Spektren von Harnstoffen, Thioharnstoffen und Guanidinen, Org. Magn. Reson. 1974, 6, 305-312.

64.
H.O. Kalinowski, H. Kessler; Korrelation der 13C-NMR-chemischen Verschiebungen von Carbonyl- und Thiocarbonyl-Gruppen, Angew. Chem. 1974, 86, 43-45; Angew. Chem. Int. Ed. Engl. 1974, 13, 90-91.

63.
Kessler, H.; Molter, M.; Dynamische NMR-Messungen an BOC-Aminosäureestern unter Verwendung von Lanthanoiden-Verschiebungsreagentien, Angew. Chem. 1973, 85, 1059-1060; Angew. Chem. Int. Ed. Engl. 1973, 12, 1011-1012.

62.
Kalinowski, H. O.; Kessler, H.; Walter, A.; Nachweis innermolekularer Beweglichekit durch NMR-Spektroskopie, XXVIII. Einfluß des Lösungsmittels auf die Rotation um die CC-Doppelbindung in Ketenaminalen, Tetrahedron 1974, 30, 1137-1144.

61.
Branik, M.; Kessler, H.; Zur Konformation geschützter Aminosäuren, I. NMR-Untersuchungen von t-BOC-Glycin, Tetrahedron 1974, 30, 781-786.

60.
Kessler, H.; Walter, A.; Direkte Beobachtung des Dissoziationsgleichgewichtes bei Tropyliumsalzen, Angew. Chem. 1973, 85, 821-822; Angew. Chem. Int. Ed. Engl. 1973, 12, 773-774.

59.
Bicker, R.; Kessler, H.; Steigel, A.; Synthesis of endo-exo-Tetracyclo[3.3.1.02,4.07,8]nonan-9-ones and the Unusual Course of Their Ketal Hydrolysis, Tetrahedron Lett. 1973, 2371-2374.

58.
Kessler, H.; Rosenthal, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXVII. Z,E-Isomerie aromatischer Diazoketone, Tetrahedron Lett. 1973, 393-396.

57.
Kalinowski, H. O.; Kessler, H.; Leibfritz, D.; Pfeffer, A.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXVI. Lösungsmittel- und säurekatalysierte Z,E-Topomerisierung eines Hydrazons, Chem. Ber. 1973, 106, 1023-1032.

56.
Kalinowski, H. O.; Kessler, H.; Fast Isomerization About Double Bonds, in: "Topics in Stereochemistry" - Allinger, N. L.; Eliel, E. L. (Eds.) John Wiley & Sons 1972, Vol. 7, 295-383.

55.
Binsch, G.; Eliel, E. L.; Kessler, H.; Eine Nomenklatur für intramolekulare Austauschprozesse, Angew. Chem. 1971, 83, 618-619; Angew. Chem. Int. Ed. Engl. 1971, 10, 570-572.

54.
Kessler, H.; Bley, P. F.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXV. Planare Stick-stoffinversion in Iminokohlensäureestern und Iminodithio-kohlensäureestern. Einfluss der Substitution am Iminokohlenstoff auf die Inversionsgeschwindigkeit am Stickstoff, Tetrahedron 1971, 27, 1687-1697.

53.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXIV. Hammett-Beziehung und sterische Einflüsse auf die Rotationen um partielle CN-Doppelbindungen in aromatischen Guanidiniumsalzen, Chem. Ber. 1971, 104, 2158-2169.

52.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXIII. Mechanismus der syn-anti-Isomerisierung in Iminen. Diastereotopie und Enantiotopie., Chem. Ber. 1971, 104, 2143-2157.

51.
Kessler, H.; Leibfritz, D.; Empirische Abschätung von Inversionsbarrieren, III. Der Einfluß benachbarter Stickstoffatome auf die Inversionsbarriere und die Natur des beobachteten Prozesses in N-Methyl- und N-Chlor-Piperidin, Tetrahedron Lett. 1970, 4297-4300.

50.
Kessler, H.; Leibfritz, D.; Empirische Abschätzung von Inversionsbarrieren, II. Stabilisierung der Stickstoff-Pyramide durch Substitution mit Sauerstoff, Tetrahedron Lett. 1970, 4293-4296.

49.
Kessler, H.; Leibfritz, D.; Empirische Abschätzung von Inversionsbarrieren, I. Inversionsbarrieren der pyramidalen Inversion in N-Halogen-substituierten Stickstoffverbindungen, Tetrahedron Lett. 1970, 4289-4292.

48.
Kessler, H.; Methoden zur Herstellung und Umwandlung von Cycloheptatrienen, in: "Houben-Weyl - Methoden der organischen Chemie" - Müller, E. (Ed.) Georg Thieme Verlag, Stuttgart 1972, Band V/1d, 302-416.

47.
Kessler, H. Kalinowski, H. O.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XXII. Syn-anti-Isomerie an der Kohlenstoff-Schwefel-Doppelbindung in Isothiuronium-salzen, Angew. Chem. 1970, 82, 666-667; Angew. Chem. Int. Ed. Engl. 1970, 9, 641-642.

46.
Kessler, H.; Kalinowski, H. O.; Mesomere Kationen, II. Synthese aliphatischer und aromatischer Isouroniumsalze, Liebigs Ann. Chem. 1971, 743, 1-9.

45.
Kessler, H.; Optische Aktivität und Inversion in der 5. Hauptgruppe des Periodensystems, Die Naturwissenschaften 1971, 58, 46-51.

44.
Leibfritz, D.; Kessler, H.; Detection of Innermolecular Motion by NMR-Spectroscopy, XXI. Hammett Correlation of Inversion Barriers in the syn-anti-Isomerization of Imino-carbonates, J. Chem. Soc., Chem. Commun. 1970, 655-657.

43.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XX. Konformation und Rotationsbarrieren in N,N'-Diarylthioharnstoffen, Tetrahedron Lett. 1970, 1595-1598.

42.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektrsokopie, XIX. Magnetische Nichtäquivalenz als Beweis für die Inversion am Stickstoff in Iminen, Tetrahedron Lett. 1970, 1423-1426.

41.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XVIII. Vergleich der Inversions-geschwindigkeiten am doppelt gebundenen Stickstoff in Guanidinen und Imidazolidiniminen, Liebigs Ann. Chem. 1970. 737, 53-60.

40.
Kessler, H.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XVII. Lineare Hammett-Korrelation von Akti-vierungsbarrieren der Rotation um CC-Doppel- und -Einfach-bindungen und CN-Einfachbindungen in Ketenaminalen, Chem. Ber. 1970, 103, 973-985.

39.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XVI. Lösungsmitteleinflüsse auf die Stickstoffinversion in Guanidinen - Rotationen um CN-Einfach- und CN-Doppelbindungen in Guanidiniumsalzen, Tetrahedron 1969, 25, 5127-5145.

38.
Kessler, H.; Kalinowski, H. O.; v. Chamier, C.; Mesomere Kationen, I. Die Synthese von S-Aryl-thiuroniumsalzen, Liebigs Ann. Chem. 1969, 727, 228-230.

37.
Kessler, H.; Strukturaufklärung durch NMR-Spektroskopie I und II, Mitt. Dtsch. Pharmaz. Ges. 1969, 39, 177-220.

36.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XV. Untersuchungen zur Inversion am doppelt gebundenem Stickstoffatom am Beispiel der Tetramethylguanidine, Tetrahedron 1970, 26, 1805-1820.

35.
Rieker, A.; Kessler, H.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XIV. Sterisch gehinderte Rotation um sigma-Bindungen, Tetrahedron Lett. 1969, 1227-1230.

34.
Kessler, H.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XIII. Nachweis gehinderter Rotationen und Inversionen durch NMR-Spektroskopie, Angew. Chem. 1970, 82, 237-253; Angew. Chem. Int. Ed. Engl. 1970, 9, 219-235.


33.
Rieker, A.; Rundel, W.; Kessler, H.; Zur Kenntnis des chinoiden Zustandes, XIV. Die Unterscheidung ortho- und para-chinoider Strukturen, Z. Naturforsch. 1969, 24b, 547-562.

32.
Rieker, A.; Kessler, H.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XII. Notiz zur Rotationsisomerie bei p-Diphenochinonen, Chem. Ber. 1969, 102, 2147-2149.

31.
Kessler, H.; Leibfritz, D.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, XI. Isomerisierungen an der CN- und CS-Doppelbindung in Guanidinium- und Thiuroniumsalzen, Tetrahedron Lett. 1969, 427-430.

30.
Kessler, H.; Kopplungskonstanten und chemische Struktur, in: "NMR-Spektroskopie - Eine Einführung mit Übungen" - Friebolin, H. (Ed.) Verlag Chemie, Weinheim 1974, 41-59.

29.
Kessler, H.; Moosmayer, A.; Rieker, A.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, X. Das Ausmaß sterischer Hinderung in substituierten Triarylmethanen und Triarylmethyl-Radikalen, Tetrahedron 1969, 25, 287-293.

28.
Kessler, H.; Gusowski, V.; Hanack, M.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, IX. Sessel-Twist-Konformationsgleichgewicht im cis-1,2-Ditert.-butylcyclohexan, Tetrahedron Lett. 1968, 4665-4670.

27.
Kessler, H.; Möhrle, H.; Zur Struktur einiger Hydroxy-piperidon(2)-Derivate, Z. Naturforsch. 1969, 24b, 301-306.

26.
Kessler, H.; Zeeh, B.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, VIII. Magnetische Nichtäquivalenz und Konformation in Äthyl-, Benzyl- und Isopropyl-substituierten 3H-Indolen, Tetrahedron 1968, 24, 6825-6831.

25.
Rieker, A.; Zeller, N.; Kessler, H.; Detection of Intramolecular Mobility by NMR Spectroscopy, VII. Nonhydrogen Tautomerism and Other Chemical Rate Processes in Cyclohexadienones, J. Am. Chem. Soc. 1968, 90, 6566-6567.

24.
Kessler, H.; Rundel, W.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, VI. Konformation und gehinderte Rotation in Disulfiden und Diseleniden, Chem. Ber. 1968, 101, 3350-3357.

23.
Müller, E.; Kessler, H.; Kupfer-I-Salz-katalysierte Diazomethanreaktion mit Hexamethyldewarbenzol, Tetrahedron Lett. 1968, 3037-3040.

22.
Kessler, H.; Rieker, A.; Rundel, W.; Intramolecular Mobility by NMR-Spectroscopy, V. Slow Rotation around Benzene-Oxygen and Benzene-Sulphur Bonds in Aromatic Ethers, Sulphides, and Disulphides, J. Chem. Soc., Chem.Commun. 1968, 475-476.

21.
Rieker, A.; Kessler, H.; Zur Kenntnis des chinoiden Zustandes, IX. Untersuchungen zur innermolekularen Beweglichkeit in para-Chinonmethiden und in den entsprechenden Phenoxylvorstufen, Tetrahedron 1968, 24, 5133-5144.

20.
Kessler, H.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, IV. Inversion am doppelt gebundenen Stickstoffatom in Phenylguanidinen, Tetrahedron Lett. 1968, 2041-2045.

19.
Kessler, H.; Stereoselektive Ätherbildung durch Dehydratisierung von Diolen, Tetrahedron Lett. 1968, 1461-1464.

18.
Kessler, H.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektrometrie, III. Magnetische Nichtäquivalenz geminaler Gruppen durch Rotationshinderung in achiralen Molekülen, Tetrahedron 1968, 24, 1857-1867.

17.
Kessler, H.; Rieker, A.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, II. Cis-trans-Isomerie bei Kern-substituierten Acetaniliden, Liebigs Ann. Chem. 1967, 708, 57-68.

16.
Kessler, H.; Rieker, A.; Nachweis innermolekularer Beweglichkeit durch NMR-Spektroskopie, I. Cis-trans-Isomere bei kernsubstituierten Acetaniliden, Z. Naturforsch. 1967, 22b, 456-457.

15.
Rieker, A.; Kessler, H.; NMR-Studien an Chinonanilen. Der Einfluß paraständiger Substituenten im Phenylring auf die thermische Isomerisierung, Tetrahedron 1967, 23, 3723-3732.

14.
Rieker, A.; Kessler, H.; Nachweis von cis-trans-Isomeren am Benzol, Tetrahedron Lett. 1967, 153-156.

13.
Kessler, H.; Müller, E.; NMR-Spektren der Alkylcycloheptatriene, Z. Naturforsch. 1967, 22b, 283-285.

12.
Kessler, H.; Rieker, A.; Direkter Nachweis der Rotation um die zentrale C-C-Doppelbindung im 3,3',5,5'-Tetra-tert.-butyl-diphenochinon-(2,4') durch NMR-Spektrometrie, Tetrahedron Lett. 1966, 5257-5262.

11.
Kessler, H.; Müller, E.; Dünnschichtchromatographische Trennung mehrkerniger Aromaten mit Pikrinsäure als Komplexbildner, J. Chromatogr. 1966, 24, 469-473.

10.
Kessler, H.; Kupfersalzkatalysierte Diazomethanreaktion mit Aromaten, Dissertation Universität Tübingen 1966.

9.
Rieker, A.; Kessler, H.; Zur Kenntnis des chinoiden Zustandes, III. Sterische Hinderung und Isomerisierung der CN-Doppelbindung in Chinonanilen, NMR- und UV-Untersuchungen, Z. Naturforsch. 1966, 21b, 939-941.

8.
Müller, E.; Kessler, H.; Zeeh, B.; Katalysierte Diazoalkan-Reaktionen, Fortschr. Chem. Forsch. 1966, 7, 128-171.

7.
Müller, E.; Kessler, H.; Untersuchungen an Diazomethanen, XXIV. Katalysierte Homologisierung von Anthracen mit Diazomethan, Liebigs Ann. Chem. 1966, 692, 58-65.

6.
Müller, E.; Kessler, H.; Die kupfersalzkatalysierte Homologisierung von Pyren mit Diazomethan, Tetrahedron Lett. 1965, 2673-2675.

5.
Müller, E.; Kessler, H.; Suhr, H.; Die katalysierte Homologisierung des Phenanthrens mit Diazomethan zum Dibenzonorcaradien, Tetrahedron Lett. 1965, 423-428.

4.
Müller, E.; Fricke, H.; Kessler, H.; Über die katalysierte Homologisierung von Naphthalin und Phenanthren mit Diazomethan, Tetrahedron Lett. 1964, 1525-1530.

3.
Müller, E.; Kessler, H.; Fricke, H.; Kiedaisch, W.; Kupfersalz-katalysierte Homologisierung von Benzolderivaten mit Diazomethan zu Cycloheptatrien-Derivaten, Liebigs Ann. Chem. 1964, 675, 63-73).

2.
Müller, E.; Fricke, H.; Kessler, H.; Homologisierung von Aromaten mit Diazomethan und Kupfersalzen, Tetrahedron Lett. 1963, 1501-1503.

1.
Müller, E.; Kessler, H.; Homologisierung von 5-Ringaromaten mit Diazomethan, Tetrahedron Lett. 1963, 1047-1049.